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Abstract Autophagy represents an intracellular degra-
dation process which is involved in both cellular
homeostasis and disease settings. In the last two decades,
the molecular machinery governing this process has been
characterized in detail. To date, several key factors regu-
lating this intracellular degradation process have been
identified. The so-called autophagy-related (ATG) genes
and proteins are central to this process. However, several
additional molecules contribute to the outcome of an
autophagic response. Several review articles describing the
molecular process of autophagy have been published in the
recent past. In this review article we would like to add the
most recent findings to this knowledge, and to give an
overview of the network character of the autophagy sig-
naling machinery.
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Introduction
The term autophagy originates from the Greek expressions
au`so´1 (autos = self) and uaceıˆm (phagein = to eat), lit-
erally meaning the self-eating of a cell. Next to the
ubiquitin–proteasome system (UPS), autophagy is a major
pathway for the degradation of intracellular cargo.
Autophagy occurs at basal levels in any cell to carry out the
proper degradation of long-lived proteins, protein aggre-
gates or damaged organelles, ultimately ensuring cellular
homeostasis. However, different stress conditions can
cause the active induction of the autophagic machinery.
These stress conditions include nutrient deprivation,
growth factor withdrawal, hypoxia, or pathogen infection.
Of note, the basic autophagic machinery is conserved
among different eukaryotes, including yeast, animals, and
plants.
Types of autophagy and morphology
In 1962, Ashford and Porter observed cytoplasmic com-
ponents, i.e., mitochondria or remnants thereof, in
lysosomes of hepatic cells which had been perfused with
glucagon [1]. In the same year, Novikoff and Essner
observed similar mitochondria-containing vacuoles in
hepatic cells from mice intravenously treated with the
detergent Triton WR-1339 [2]. They termed these struc-
tures cytolysomes. In 1963, Christian de Duve suggested
the name ‘‘autophagic vacuoles’’ for these cytolysomes and
‘‘autophagy’’ for the process of cellular self-eating [3].
Today, autophagy has become one of the most intensely
investigated fields of cell biological research. This might
partly be attributed to the fact that the process of autophagy
or its dysregulation contribute to the onset of diverse
human diseases or clinically relevant processes, including
cancer, neurodegeneration, immune responses, or aging [4–
7]. There exist three types of autophagy, i.e., macroau-
tophagy, microautophagy, and chaperone-mediated
autophagy [8]. Within chaperone-mediated autophagy,
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target proteins are directly recognized by cytosolic chap-
erones and transported across the lysosomal membrane [8].
Microautophagy describes a process by which the lysoso-
mal membrane directly engulfs small portions of the
cytoplasm [8]. During the process of macroautophagy
(herein referred to as autophagy), cytoplasmic cargo is
enveloped within a double-membraned vesicle, called
autophagosome. Autophagosomes are transported to and
fuse with lysosomes, leading to the generation of
autolysosomes. Within autolysosomes, the sequestered
cargo and the inner membrane of the autophagosome are
degraded, and the resulting molecular building blocks such
as amino acids or fatty acids are transported back to the
cytosol through lysosomal permeases and are available for
anabolic processes [9, 10]. Autophagy might be non-se-
lective, leading to the bulk degradation of cytoplasm.
However, in recent years different selective forms of
autophagy have been identified and characterized, leading
to the specific degradation of organelles or pathogens.
These selective pathways include the autophagic degrada-
tion of mitochondria (mitophagy), peroxisomes
(pexophagy), endoplasmic reticulum (reticulophagy or ER-
phagy), ribosomes (ribophagy), protein aggregates (ag-
grephagy), lipid droplets (lipophagy), spermatozoon-
inherited organelles following fertilization (allophagy),
secretory granules within pancreatic cells (zymophagy), or
intracellular pathogens (xenophagy) [11–14].
The formation of autophagosomes is a central hallmark
of autophagy, and includes different discrete steps, i.e.,
nucleation, elongation and closure of the double-mem-
braned vesicle. The cellular source of the autophagosomal
membrane has been controversially discussed in the recent
past. In yeast, a specific platform for the biogenesis of
autophagosomes has been identified, the pre-autophagoso-
mal structure (PAS) [15]. The PAS is a single punctate
structure adjacent to the yeast vacuole, where most of the
Atg proteins (see below) are present [8]. From the PAS the
phagophore (also referred to as isolation membrane, IM) is
generated, which envelopes cytoplasmic cargo to ulti-
mately form the complete autophagosome [8]. In 2008,
Axe et al. reported that the phosphatidylinositol 3-phos-
phate (PtdIns3P)-binding protein double FYVE domain-
containing protein 1 (DFCP1) translocates to a punctate
compartment upon nutrient starvation in mammalian cells
[16]. The observed compartment is in dynamic equilibrium
with the ER and provides a platform for the generation of
the phagophore and the release of fully formed
autophagosomes [16]. Since these structures were seen in
association with the underlying ER forming an X-like
shape, the authors termed them ‘‘omegasomes’’ [16].
Interestingly, so far no DFCP1 homolog has been reported
for yeast [16]. Two further groups confirmed the physical
connection between the ER and the phagophore by 3D
electron microscopy [17, 18]. Collectively, these results
strongly suggest that the phagophore originates from spe-
cialized subdomains of the ER. However, different other
sources for autophagosomal membrane lipids have been
suggested, including mitochondria, the Golgi complex,
recycling endosomes, the nuclear envelope and the plasma
membrane (reviewed in [8, 19, 20]). For example, it has
been reported that mitochondria supply membranes for
autophagosomes during starvation [21]. Apparently,
autophagosome formation is dependent on ER/mitochon-
dria connections. It has been proposed that these
connections are necessary to transfer phosphatidylserine
(PS) to the mitochondria, where PS is converted to phos-
phatidylethanolamine (PE). PE in turn is the target of Atg8/
LC3-conjugation (described in ‘‘Two ubiquitin-like con-
jugation systems in autophagy: Atg12/ATG12–Atg5/ATG5
and Atg8/LC3–PE’’). It has also been reported that
autophagosomes themselves form at ER–mitochondria
contact sites [22]. Recent data indicate that several specific
organelles contribute to autophagosome formation, e.g.,
ER exit sites (ERES), coat protein II (COPII)-coated
vesicles leaving the ERES, or the ER–Golgi intermediate
compartment (ERGIC) [23–25]. Biazik et al. reported that
forming phagophores can have multiple simultaneous
membrane contact sites with surrounding organelles [26].
Presumably, different sources contribute to the completion
of autophagosomes, presumably also depending on the
autophagy-inducing stimulus and on the cargo to be
degraded.
Molecular regulation of autophagy
In the late 1990s, another era of autophagy research has
evolved, leading to the molecular characterization of this
process [27]. In 1993, Tsukada and Ohsumi reported the
isolation and characterization of 15 S. cerevisiae mutants
that displayed defective autophagy and named them apg1-
15 (autophagy) [28]. Similar screens were performed by
other research groups, and the identified mutants defective
in either autophagy, pexophagy, or the cytoplasm-to-vac-
uole pathway were called aut, cvt, pdd, gsa, pag, or paz,
respectively [29–35]. In 2003, a unified nomenclature for
the so-called autophagy-related genes/proteins, Atgs, was
proposed [30]. Recently, yeast Atg39 and Atg40 have been
identified as receptors which are apparently involved in the
selective removal of the cytoplasmic and perinuclear ER
and the nucleus [36]. Most of the yeast Atgs have homo-
logs in the mammalian system (abbreviated as ATGs).
However, sometimes homology is only based on function
but not on sequence. Additionally, there exists one mam-
malian ATG, ATG101, which does not have an obvious
counterpart in yeast [37, 38]. Frequently, in mammals
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different isoforms of a certain yeast Atg exist. Furthermore,
different non-ATG proteins are involved in the regulation
and process of autophagy, e.g., the mammalian/mechanis-
tic target of rapamycin (mTOR), AMPK, AKT, AMBRA1,
BCL2, DFCP1, or vacuolar protein sorting protein 34
(VPS34), which is the catalytic subunit of the class III
phosphatidylinositol 3-kinase (PtdIns3K). Finally, different
functions of ATGs in non-autophagic processes have been
reported and are likely to emerge in the future (reviewed in
[39]).
Functionally, mammalian ATGs can be subdivided in
six functional clusters (Fig. 1): (1) the ULK1–ATG13–
FIP200–ATG101 protein kinase complex; (2) the PtdIns3K
class III complex containing the core proteins VPS34,
VPS15 and Beclin 1; (3) the PtdIns3P-binding WIPI/
ATG18–ATG2 complex; (4) the multi-spanning trans-
membrane protein ATG9A; (5) the ubiquitin-like ATG5/
ATG12 system and (6) the ubiquitin-like ATG8/LC3
conjugation system (reviewed in [8]). These six modules
regulate different steps during autophagosome biogenesis,
i.e., vesicle nucleation, elongation of the autophagosomal
membrane, and autophagosome completion. In the fol-
lowing, the autophagy-related functions of these six
modules and their crosstalk will be described in detail, with
the main focus laid onto the autophagy-initiating ULK1
kinase complex.
The Atg1/ULK1 complex
The yeast Atg1–Atg13–Atg17 complex
In 1997, Matsuura et al. showed that the apg1/atg1 gene
discovered in their first screen for autophagy-defective
yeast strains encodes a protein kinase (Apg1p/Atg1), and
they reported an overall homology to C. elegans UNC-51
protein [40]. Furthermore, they showed that Atg1 overex-
pression suppressed the autophagy-defective phenotype in
the Dapg13/atg13 strain, indicating a linkage between Atg1
Fig. 1 Functional clusters of
autophagy signaling. 1 The
ULK1–ATG13–FIP200–ATG101
protein kinase complex, 2 the
PtdIns3K class III complex
containing the core proteins
VPS34, VPS15 and Beclin 1, 3 the
multi-spanning transmembrane
protein ATG9A, 4 the PtdIns3P-
binding WIPI/ATG18–ATG2
complex, 5 the ubiquitin-like
ATG5/ATG12 system and 6 the
ubiquitin-like ATG8/LC3
conjugation system. For the ULK1
complex, mTOR-dependent
inhibitory phosphorylations are
depicted as red arrows, and
ULK1-dependent activatory
phosphorylations are depicted as
black arrows. For the PtdIns3K
class III complex, the mutually
exclusive interactions of ATG14
or UVRAG with Beclin 1 are—for
simplicity—shown within one
complex
Autophagy signal transduction by ATG proteins: from hierarchies to networks 4723
123
and Atg13 [41]. In the following years, the exact molecular
details of the Atg1-dependent initiation of autophagy were
deciphered. Yeast Atg1 associates with pathway-specific
sets of Atg proteins, regulating either canonical autophagy
or the yeast-specific cytoplasm-to-vacuole targeting (Cvt)
pathway, respectively (reviewed in [42–45]). During
canonical autophagy, Atg1 associates with Atg13, Atg17,
Atg29 and Atg31. In contrast, during the Cvt pathway,
Atg1 interacts with Atg11, Atg13, Atg20, Atg24 and Vac8
[44]. Accordingly, Atg17, Atg29 and Atg31 are selectively
important for autophagy [46–48]. These three Atgs form a
complex which is constitutively assembled and represents a
scaffold for the recruitment of further Atgs to the PAS [49–
51]. Upon starvation, Atg1 binds to Atg17, and this asso-
ciation is primarily mediated by Atg13 [52, 53]. Both the
Atg1–Atg13 kinase complex and the autophagy-specific
Atg17–Atg29–Atg31 complex cooperatively regulate the
subsequent recruitment of downstream Atgs to the PAS,
and for this function their physical interaction is mandatory
[50, 54].
In 1998, it was reported that autophagy is negatively
regulated by the protein kinase target of rapamycin (TOR),
and that rapamycin accordingly induces the autophagic flux
[55]. Two years later, Kamada et al. published a pioneering
work demonstrating that this TOR-dependent control of
autophagy is mediated by the Atg1 kinase complex [47].
The authors observed that both starvation and rapamycin
enhanced the kinase activity of Atg1. Furthermore, Atg13
is hyperphosphorylated by TOR, resulting in a reduced
affinity to Atg1. Accordingly, rapamycin treatment favors
the dephosphorylation of Atg13 and its association with
Atg1, resulting in increased Atg1 activity. Finally, the
authors reported that rapamycin-induced Atg1 activity was
decreased in the Datg17 strain, indicating that both Atg13
and Atg17 are important for Atg1 activation [47]. Subse-
quently the same group discovered that TOR
phosphorylates Atg13 at S437, S438, S646, and S649. The
authors mutated these four sites and four additional puta-
tive TOR sites (S348, S496, S535, S541) to alanines, and
demonstrated that expression of the nonphosphorylatable
Atg13-8SA mutant induced autophagy independently of
TOR activity or nutrient status, apparently mimicking
rapamycin treatment [56].
Notably, it has also been reported that Atg1 and Atg13
constitutively interact in vivo, irrespective of nutrient
availability [57]. This situation would resemble the ULK1
complex constitution in higher eukaryotes (see below).
Although the authors confirmed that binding of Atg13 to
Atg1 indeed promotes its kinase activity and is important
for efficient autophagy in vivo, the described observation
would suggest that Atg1 activation in yeast is not exclu-
sively controlled by regulated Atg13 binding, but rather
involves additional levels of control. This could include
conformational alterations or recruitment of additional
factors regulated by the Atg13 phospho-status. Addition-
ally, Atg1 phosphorylation itself is important for
activation, as confirmed by two independent studies [58,
59]. However, next to TOR-regulation and Atg1
autophosphorylation additional kinases have been impli-
cated in the regulation of the yeast Atg1–Atg13 complex,
including PKA, Ksp1, Sch9 (yeast ortholog of mammalian
AKT or p70S6K), or Snf1p [yeast ortholog of the mam-
malian AMP-activated protein kinase (AMPK)] [60–64].
Additionally, the phospho-status of the Atg1–Atg13 com-
plex is likely to be regulated by phosphatases [65]. With
regard to the downstream Atg1 substrates which regulate
the initiation of autophagy in yeast, the current knowledge
is less complete. Although different in vitro substrates have
been identified for Atg1 by a global phosphorylation
analysis, including Atg8 and Atg18, their in vivo relevance
awaits further confirmation [66]. Previously it has been
reported that Atg9 cycling depends on Atg1–Atg13 (de-
scribed in ‘‘Atg9/ATG9A’’), but apparently the kinase
activity of Atg1 is not important [67]. Nevertheless,
recently it has been reported that Atg1 can directly phos-
phorylate Atg9 and that this phosphosphorylation is
required for the efficient recruitment of Atg8 and Atg18 to
the site of autophagosome formation and subsequent
expansion of the IM [68]. Identified Atg1 substrates are
summarized in Table 1.
In the last few years, the understanding of the signal
transduction by the yeast Atg1 complex has significantly
been complemented by several works investigating its
structure. Ragusa et al. reported the crystal structure of a
2:2:2 complex of Atg17, Atg29 and Atg31 [69]. Atg17 is
crescent-shaped with a 10 nm radius of curvature. During
PAS organization and autophagy, the Atg17–Atg29–Atg31
complex dimerizes, and each dimer contains two complete
crescents. The C-terminal ‘‘early autophagy targeting/
tethering’’ (EAT) domain of Atg1 senses membrane cur-
vature, dimerizes, and tethers lipid vesicles [69]. This
double-crescent/S-shape architecture was also reported by
Chew et al. [70]. The crystal structure of the N-terminal
domain of yeast Atg13 has also been published [71]. Atg13
contains a HORMA (Hop1p, Rev7p, Mad2) domain at its N
terminus. The HORMA domain is dispensable for the
interaction with Atg1 or Atg13 recruitment to the PAS, but
is apparently required for autophagy and the recruitment of
the PtdIns3K subunit Atg14 (see ‘‘The PtdIns3K class III
complex’’) [71]. Furthermore, it has been reported that the
Atg13 HORMA domain recruits Atg9 vesicles during
autophagosome formation [72]. Fujioka et al. reported the
X-ray crystallographic analysis of the interaction of yeast
Atg13 with Atg1 and Atg17 [73]. Atg13 binds tandem
microtubule interacting and transport (tMIT) domains in
Atg1 via a 2-part MIT interacting motif (residues
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460–521). Additionally, the Atg17-binding region was
mapped to amino acids 424–436 of Atg13. The authors
propose that starvation-induced dephosphorylation of
specific serine residues in Atg13 enhances the interaction
with both Atg1 and Atg17, directly explaining the TOR-
dependent regulation of these interactions described above.
The Atg1–Atg13 interaction was essentially confirmed by
Stjepanovic et al. [74]. They report that Atg1–Atg13
complex binds as a unit to the Atg17–Atg31–Atg29 scaf-
fold with *10-lM affinity via Atg13. The resulting
complex consists primarily of a dimer of pentamers in
solution [74]. Recently, it has been shown that the PAS
contains *28 copies of Atg17 and—upon autophagy
induction—similar numbers of Atg1 and Atg13 molecules
[75]. Furthermore, they observe tetramers of Atg1 pen-
tamers that assemble via Atg17–Atg31–Atg29, ultimately
proposing a model for the higher organization of the Atg1
complex at the PAS [75]. Further aspects about the struc-
tural analyses of the Atg1 complex have been summarized
in a recent review article by Noda and Fujioka [76].
The ULK1–ATG13–FIP200–ATG101 complex in higher
eukaryotes
Atg1 has orthologs in the nematode C. elegans and the fruit
fly D. melanogaster, i.e., UNC-51 and ATG1, respectively.
In mammals, so far five orthologs have been identified, i.e.,
ULK1, ULK2, ULK3, ULK4, and STK36 (also termed
Fused homolog) (reviewed in [42–45, 77]). In 1998, mur-
ine ULK1 was cloned and its similarity to yeast Atg1 and
C. elegans UNC-51 was reported [78]. ULK1 consists of an
N-terminal serine/threonine protein kinase domain, fol-
lowed by a proline/serine (P/S)-rich domain and a
conserved C-terminal domain (CTD). Shortly afterwards
the same group reported the identification of human ULK1
and murine ULK2, respectively [79, 80]. In 2007, ULK1
was identified as an autophagy-modulating kinase by an
siRNA screen of the kinome [81]. Knockdown of ULK1 in
HEK293 cells blocked the autophagic response upon amino
acid starvation or rapamycin treatment, respectively. ULK1
and ULK2 colocalize with ATG16L1 (see ‘‘Two ubiquitin-
like conjugation systems in autophagy: Atg12/ATG12–
Atg5/ATG5 and Atg8/LC3–PE’’) and are accordingly tar-
geted to the phagophore [82]. Notably, knockdown of
ULK2 did not reveal any effect on autophagy induction in
HEK293 cells, indicating that at least in this cellular sys-
tem ULK1 and ULK2 cannot compensate each other [81].
However, compensatory roles of these two kinases can be
deduced from the corresponding knockout mouse models.
ULK1-deficient mice are viable and survive neonatal
starvation periods [83]. Nonetheless, these mice reveal a
delayed clearance of mitochondria from reticulocytes,
indicating some differential roles of ULK1 and ULK2 for
selective autophagy in general and for mitophagy in par-
ticular. Similarly, Ulk2-/- mice are viable and do not show
an overt autophagy phenotype [84]. In contrast, ULK1/2-
double-deficient mice die shortly after birth, similar to
mice deficient for ATG3, ATG5 or ATG7 [84]. Further-
more, autophagy induced by amino acid starvation is
blocked in MEFs of these double-deficient mice [84]. The
homology between ULK1 and ULK2 comprises the full
length of the kinases, i.e., kinase domain, PS-rich domain,
and CTD. In contrast, homology towards the other ULK
family members is restricted to the kinase domain (re-
viewed in [42–45, 77]). However, ULK3 overexpression
induced autophagy and premature senescence in a human
fetal lung fibroblast cell line [85].
In 2007, Meijer et al. analyzed the degree of conserva-
tion for different Atgs/ATGs between different species
[86]. They predicted that the protein KIAA0652 represents
the human ortholog of yeast Atg13. Notably, they failed to
identify Atg17 and Atg29 orthologs in higher eukaryotes
[86]. Additionally, an Atg31 ortholog has not been reported
in higher eukaryotes so far [8, 43]. However, in 2008 Hara
et al. reported that the focal adhesion kinase family inter-
acting protein of 200 kDa (FIP200) is an ULK1-interacting
protein (Fig. 1, panel 1) [82]. Originally, FIP200 has been
identified as a proline-rich tyrosine kinase 2 (Pyk2)- and
focal adhesion kinase (FAK)-interacting protein which
inhibits Pyk2 and FAK by direct binding to the kinase
domains [87, 88]. FIP200 is also referred to as
retinoblastoma 1-inducible coiled-coil 1 (RB1CC1) [89].
FIP200 is ubiquitously expressed and is involved in mul-
tiple cellular processes (reviewed in [90]). According to
these multiple roles performed by FIP200, several FIP200-
interacting proteins next to Pyk2 and FAK have been
identified so far, including ATG16L1 (see ‘‘Two ubiquitin-
like conjugation systems in autophagy: Atg12/ATG12–
Atg5/ATG5 and Atg8/LC3–PE’’), TSC1, p53, PP1, ASK1,
TRAF2, Arkadia E3-ligase, COP1 E3-ligase, hSNF5,
PIASy, b-catenin, ActA, and stathmin [91–105]. FIP200
comprises a putative nuclear localization signal (NLS)
within the N-terminal half of the protein, a large coiled-coil
domain and a leucine zipper motif at the C terminus [90].
FIP200 has been reported to localize in the cytoplasm, the
nucleus and at focal adhesions [90]. The interaction
between ULK1 and FIP200 requires the CTD of ULK1,
and—similar to ULK1/2—FIP200 localizes to the phago-
phore upon starvation [82]. Furthermore, in FIP200-
deficient MEFs autophagy induction is blocked, and the
defect in autophagosome formation occurs downstream of
mTOR [82]. Within the ‘‘Discussion’’ section of this first
report demonstrating the importance of FIP200 for auto-
phagy, the authors already speculate that FIP200 might
represent the functional counterpart of yeast Atg17, due to
several functional and architectural similarities [82, 106].
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As described below, this assumption was subsequently
confirmed by several reports.
Following the prediction by Meijer et al., several groups
demonstrated that KIAA0652 indeed represents the human
ATG13 ortholog (Fig. 1, panel 1) [107–110]. Furthermore,
three of these reports deciphered the mechanistic details
how mTOR regulates autophagy through the mammalian
ULK1–ATG13–FIP200 complex. Human ATG13 is a 517
aa protein (isoform 1) and exhibits a 16 % identity to its
yeast ortholog [109]. Chan et al. showed that knockdown
of ATG13 blocks starvation-induced LC3 lipidation and
ATG9A redistribution. They found that ATG13 binds to
the CTD of Ulk1/2 [107]. Additionally, it was demon-
strated that ATG13 serves as substrate for ULK1/2 and that
the association between ULK proteins and ATG13 is not
affected by the nutritional status or ATG13 phosphoryla-
tion [107]. In three almost simultaneously published
studies, the mechanistic details how the mammalian
ULK1–ATG13–FIP200 complex regulates autophagy and
how mTOR transduces signals to this complex were elu-
cidated [108–110]. ATG13 interacts with both ULK1/2 and
FIP200 [108–110]. It appears that the association between
ULK1 and FIP200 significantly depends on ATG13, but
one group also demonstrated that ULK1 can independently
interact with ATG13 and FIP200 [108]. Kim’s group
reported that the last 75 aa of ATG13 are mandatory for
ULK1/2 binding, and the last 134 aa for binding of both
FIP200 and ULK1/2 [110]. We have recently fine-mapped
the interaction sites between ATG13/ULK1 and ATG13/
FIP200, respectively. It appears that the last three amino
acids of ATG13 control binding to ULK1 and that the
peptide sequence encoded by exon 14 of the human ATG13
gene mediates binding to FIP200 ([111] and unpublished
results). Size exclusion analyses by Mizushima’s group
revealed that ULK1, ATG13 and FIP200 can be detected
within a 3-MDa complex [109]. FIP200 is exclusively
found in this mega-complex, and this complex cannot be
detected in FIP200-/- cells, indicating that FIP200 sig-
nificantly contributes to the elution volume of this
complex. The Jiang group performed size exclusion
experiments with recombinant proteins and observed the
three components within a complex with a molecular
weight[1 MDa [108]. All three components of the com-
plex localize to the phagophore upon induction of
autophagy, and the assembly of the complex is not sensi-
tive to starvation. Furthermore, ATG13 and FIP200 are
required for maximal ULK1 kinase activity, ULK1 stabil-
ity, and ULK1 recruitment to the phagophore. In turn, both
ATG13 and FIP200 are substrates for ULK proteins. All
three groups observed that either starvation or rapamycin
treatment results in a faster migration of ULK1 and ATG13
in SDS-PAGE, and all three groups clearly demonstrated
that mTOR phosphorylates both ULK1 and ATG13 [108–
110]. Furthermore, Hosokawa et al. showed that the mTOR
complex 1 (mTORC1) associates with the 3-MDa complex
under nutrient-rich conditions and dissociates under star-
vation [109]. This interaction is mediated by the mTORC1
component RAPTOR and the PS-domain of ULK1. Of
note, the mTORC1 binding site has alternatively been
mapped to the kinase domain of ULK1 [112]. Accordingly,
the ATG13-interacting CTD of ULK1 is not necessary for
mTORC1 recruitment [109].
The fourth component of the ULK kinase complex has
been identified and characterized independently by two
groups. This component does not have any obvious
ortholog in S. cerevisiae and was thus termed ATG101 [37,
38]. Of note, the closely related fission yeast S. pombe
harbors an ATG101 ortholog (alternatively named Mug66)
[37, 113–115]. ATG101 directly interacts with the ULK1
kinase complex through ATG13, and this association is
independent of nutrient supply [37]. Mercer et al. mapped
the ATG101-binding site in ATG13 to amino acids
112–220 [38]. In contrast to the results described above,
the binding site of ATG13–ATG101 within ULK1 was
mapped to the N-terminal half of the PS-rich domain,
proximal to the kinase domain [38]. Notably, siRNA-me-
diated depletion of ATG101 suppresses GFP-LC3 puncta
formation or GST-BHMT fragmentation, indicating that
ATG101 is essential for autophagy [37, 38]. Although
yeast and higher eukaryotes share some overlapping com-
ponents of the Atg1/ULK1 complexes, e.g., Atg1/ULK1
itself and ATG13, there exist significant differences in
complex constitution. As described above, yeast Atg11 and
Atg17 serve as scaffolds during Cvt pathway or autophagy,
respectively. It appears that FIP200 and ATG101 have
overtaken some corresponding functions, since primary
sequence orthologs of Atg11 and Atg17 do not exist in
higher eukaryotes. Although FIP200 presumably represents
a functional Atg17 ortholog [106], it should be noted that
FIP200 is listed as Atg11 family member in the NCBI
Pfam database and is structurally similar to S. pombe and
C. elegans Atg11s [116]. Additionally, ATG101 has been
reported to show similarity to yeast Atg17 [116].
To date, structural analyses of the ULK1 complex in
higher eukaryotes remain less advanced compared to their
yeast orthologs, but some interesting observations have
recently been published. Suzuki et al. reported the struc-
tural analysis of the S. pombe Atg101–Atg13 complex
[115]. The fission yeast S. pombe is a suitable model sys-
tem for studying the mammalian ULK complex, since it
conserves Atg1, Atg13, Atg17 and Atg101 orthologs, but
not Atg29 and Atg31 [114, 115]. S. pombe Atg101 harbors
a HORMA domain similar to that of Atg13. The HORMA-
domain protein Mad2 has an open (O) and a closed
(C) conformation, and it appears that Atg101 has a locked
O-Mad2-like confirmation and stabilizes the C-Mad2-like
4728 S. Wesselborg, B. Stork
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conformation of Atg13. This in turn leads to the recruit-
ment of downstream factors to the autophagosome
formation site. In a parallel work, Michel et al. reported the
crystal structure of human ATG101 [117]. The authors
confirm the existence of ATG101 in a O-Mad2-like con-
formation. They also describe the presence of three large
insertions relative to Mad2 (extensions 1, 2 and 3), which
are all located to one pole of the molecule. Interestingly,
extension 1 is missing in S. pombe Atg101, and extension 3
is significantly shorter [117]. The exact function of these
extensions has to be unraveled in the future. Finally, the
crystal structure of the ULK1 kinase domain in complex
with different inhibitors has been reported by Lazarus et al.
[118]. Whether the interaction mode between ATG13 and
ULK1 is conserved in higher eukaryotes awaits further
clarification, since (1) yeast and mammalian Atg13/ATG13
are not very homologous and (2) we observed that this
interaction is—not necessarily directly mediated but at
least—controlled by the last three amino acids of ATG13
[111].
Taking all the experimental observations summarized
above into consideration, the following model has been
established [Figs. 1 (panel 1), 2]: under nutrient-rich con-
ditions, mTORC1 associates with the ULK1–ATG13–
FIP200–ATG101 complex and phosphorylates ULK1 and
ATG13. Under starvation conditions, mTORC1 dissociates
from this mega-complex, and the inhibitory mTOR-depen-
dent phospho-sites within ULK1 and ATG13 become
dephosphorylated. Active ULK1 then autophosphorylates
and phosphorylates ATG13 and FIP200, ultimately leading
to the initiation of autophagosome formation. However, this
proposed model leaves central remaining questions open,
which will be partially addressed below or are currently
being investigated: (1) how does mTOR-dependent phos-
phorylation of ULK1 and ATG13 keep the constitutively
assembled complex in an inactive state; (2) which phos-
phatases dephosphorylate these inhibitory mTOR-sites and
how does this contribute to the activation of the complex; (3)
how is the phospho-status of ULK1 and ATG13 regulated in
mTOR-independent pathways; (4) what is the role of the
ULK-dependent phospho-sites in ATG13 and FIP200; (5)
are additional interacting proteins and/or further post-trans-
lational modifications of this complex necessary for its
autophagy-inducing function, andmost importantly; (6) how
does the ULK1–ATG13–FIP200–ATG101 complex initiate
the downstream autophagy signaling machinery?
Regulation of the ULK complex by post-translational
modifications and downstream effectors
According to the above described model, the phospho-
status of the ULK1–ATG13–FIP200–ATG101 complex is
central for the regulation of autophagic processes. In
general, global phosphorylation of ULK1 and ATG13 is
decreased under starvation conditions and FIP200 phos-
phorylation is decreased under fed conditions [44, 45, 108–
110]. In other words, it appears that the phospo-status of
ULK1 and ATG13 primarily depends on mTOR, whereas
the phospho-status of FIP200 mainly depends on ULK1,
respectively. Several groups identified phosphorylation
sites within ULK1 by mass spectrometry (see supplemental
Table 1), both under nutrient-rich and starvation conditions
[119–121]. These phospho-acceptor sites are distributed
over the full length protein, i.e., within the kinase domain,
the PS-rich domain and the CTD. These proteomic screens
revealed that some of the sites are constitutively phos-
phorylated whereas others show a dependency on the
nutritional conditions. With regard to ULK1-dependent
sites in ATG13, seven phospho-acceptor sites have been
published [121–123]. The SILAC-based approach by
Shang et al. revealed that total phosphorylation levels of
ATG13 were low under nutrient-rich conditions and stayed
largely unaltered upon starvation [121]. The authors could
only identify phosphorylation of ATG13 S361 (isoform 1),
and phosphorylation of this site did not significantly
change during starvation [121]. This would indicate that
rather the ULK1 phospho-status than the ATG13 phospho-
status governs autophagy initiation. Joo et al. showed that
the Hsp90–Cdc37 chaperone complex regulates mitophagy
by modulating ULK1 stability and function. They reported
that ULK1-mediated phosphorylation of ATG13 at S318
(isoform 2; corresponds to S355 in isoform 1) is required
for the release of ATG13 from an ULK1–Hsp90–Cdc37
complex and for the recruitment of ATG13 to damaged
mitochondria, where it contributes to Parkin-mediated
mitophagy (see ‘‘Two ubiquitin-like conjugation systems in
autophagy: Atg12/ATG12–Atg5/ATG5 and Atg8/LC3–
PE’’) [123]. These results might account for the selective
role of ULK1 for the mitochondrial clearance during
reticulocyte development described above, and additionally
the data suggest a phosphorylation-dependent regulation of
the ULK1–ATG13 interaction during selective autophagy
processes. We were able to identify five ULK1-dependent
phospho-sites of ATG13 by an in vitro kinase assay (cor-
responding to S48, T170, T331, T428 and T478 in human
isoform 2). However, mutation of these five sites did not
alter starvation-induced autophagy in chicken DT40 B
lymphocytes, although starvation-induced autophagy is
completely blocked in ATG13-/- DT40 cells [122].
Additionally, mTOR-dependent sites of mammalian
ATG13 have not been reported so far [42, 45]. Recently,
ULK1-dependent phospho-sites of FIP200 have been
identified, but their functional relevance awaits further
clarification [124].
On the basis of its central role for the regulation of the
ULK1–ATG13–FIP200–ATG101 complex, mTOR has
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been dubbed the ‘‘gatekeeper’’ of autophagy (Fig. 2). The
protein kinase mTOR integrates (1) nutrient signals, e.g.,
generated by growth factors or amino acids; (2) energy
signals, e.g., controlled by the cellular AMP/ATP ratio; and
(3) stress signals such as hypoxia or DNA damage
(reviewed in [125–127]). The growth factor and energy
inputs are essentially controlled by the serine/threonine
protein kinases AKT and AMP-activated protein kinase
(AMPK), which both function as upstream regulators of
mTOR. Both kinases have also been implicated in the
Fig. 2 Signaling machinery upstream and downstream of the ULK1
complex. In recent years, the mTORC1-dependent regulation of the
ULK1–ATG13–FIP200–ATG101 complex has been deciphered.
Under nutrient-rich conditions, mTORC1 associates with the
ULK1–ATG13–FIP200–ATG101 complex and phosphorylates
ULK1 and ATG13. Under starvation conditions or upon treatment
with mTOR inhibitors, mTORC1 dissociates from this mega-
complex, and the inhibitory mTOR-dependent phospho-sites within
ULK1 and ATG13 become dephosphorylated. Active ULK1 then
autophosphorylates and phosphorylates ATG13 and FIP200, ulti-
mately leading to the initiation of autophagosome formation [44, 45,
108–110]. The depicted substrates of ULK1 are listed in Table 1.
MTOR has been established as central ‘‘gatekeeper’’ of autophagy,
since this kinase integrates (1) nutrient signals, e.g., generated by
growth factors or amino acids; (2) energy signals, e.g., controlled by
the cellular AMP/ATP ratio; and (3) stress signals such as hypoxia or
DNA damage. The Ser/Thr kinase mTOR is the catalytic subunit of
two distinct kinase complexes, i.e., mTORC1 and mTORC2. The two
complexes contain unique associated proteins which serve as
scaffolds and determine the substrate specificity of the complexes,
i.e., regulatory-associated protein of mTOR (RAPTOR) and rapamy-
cin-insensitive companion of mTOR (RICTOR), respectively [396–
398]. Next to these two proteins, the two complexes both harbor
additional specific interacting proteins and share some components.
Amino acids are sensed by the RAG family of small GTPases. Active
RAG heterodimers translocate mTORC1 to lysosomal surfaces, where
they bind to the so-called Ragulator complex [399]. On the surface of
lysosomes, mTORC1 is activated by another small GTPase termed
RAS-homologue enriched in brain (RHEB). The presence of growth
factors is transmitted to mTOR via AKT. AKT phosphorylates
tuberous sclerosis 2 protein (TSC2; also termed tuberin), which
together with TSC1 (also termed hamartin) forms the TSC1–TSC2
complex. AKT-dependent phosphorylation of TSC2 inhibits the
GTPase activating protein (GAP) activity of the TSC1–TSC2
complex for RHEB, thus promoting mTORC1 activation by GTP-
loaded RHEB [400–402]. Alternatively, AKT phosphorylates
PRAS40, which is subsequently bound by 14-3-3 proteins and cannot
inhibit mTORC1 anymore [403–405]. Low energy levels as sensed by
a high AMP/ATP ratio are transmitted to mTORC1 via AMPK.
AMPK can—like AKT—phosphorylate TSC2. However, AMPK-
dependent TSC2 phosphorylation leads to increased GAP activity of
the TSC1-TSC2 complex and thus to mTORC1 inhibition [406, 407].
Alternatively, AMPK can directly inhibit mTORC1 by RAPTOR
phosphorylation [137]. Stress signals like hypoxia, DNA damage,
TRAIL or Ca2? signals also inhibit mTORC1 via AMPK and/or the
TSC1-TSC2 complex (reviewed in [42, 126, 127]). Finally, AKT and
AMPK can directly regulate ULK1, and ULK1 can—by negative
feedback loops—regulate the upstream kinases mTORC1 and AMPK
[120, 121, 128, 140, 141, 143, 153, 154]
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direct regulation of the ULK1 kinase complex (Fig. 2). The
serine/threonine kinase AKT (also termed protein kinase B,
PKB) translates signals received by receptor tyrosine
kinases or receptor-associated tyrosine kinases into a
diverse array of intracellular responses, including cell cycle
control, metabolism, apoptosis, or autophagy. Bach et al.
showed that ULK1 serves as direct substrate for AKT. The
authors observed that insulin induces the AKT-dependent
phosphorylation of ULK1 at S775 (human sequence) [128].
AMPK is the main sensor for cellular energy levels. AMPK
consists of three subunits, i.e., the catalytic a-subunit and
the regulatory b- and c-subunits, respectively. Addition-
ally, there exist several isoforms of the different subunits,
i.e., a1–2, b1–2, and c1–3 (reviewed in [129–131]). In
order to exert its full catalytic activity, the a-subunit has to
be phosphorylated within its activation loop at T172.
Besides T172 phosphorylation of the a-subunit, the het-
erotrimeric AMPK complex is controlled by the regulatory
b- and c-subunits. In 2001, Wang and colleagues reported
that the yeast AMPK-ortholog Snf1p is a positive regulator
of autophagy and probably functions via Atg1 and/or
Atg13, respectively [63]. Subsequently, several reports
analyzed the role of AMPK for mammalian autophagy.
Although an initial study reported that the AMPK-acti-
vating substances adenosine, AICA riboside and N6-
mercaptopurine riboside inhibit autophagy [132], subse-
quently several works supported a positive regulatory role
of AMPK for mammalian autophagy [133–136]. Generally,
this positive effect of AMPK on autophagy has been
attributed to its capability to inhibit mTOR (see Fig. 2).
The inhibition of mTORC1 can be achieved by two dif-
ferent pathways, either by AMPK-mediated
phosphorylation of the upstream regulator tuberous scle-
rosis complex 2 (TSC2) or by AMPK-mediated
phosphorylation of the mTORC1-subunit RAPTOR (see
Fig. 2) [137, 138]. However, in recent years a direct reg-
ulation of the ULK1–ATG13–FIP200–ATG101 complex
by AMPK has been established, which is accordingly
mTOR-independent. How does this direct regulation work?
We and others demonstrated that AMPK directly interacts
with ULK1 ([112, 120, 121, 139–142]. We discovered that
ULK1 phosphorylates all three subunits of AMPK. It
appears that ULK1-dependent phosphorylation of AMPK
negatively regulates both its activation and activity, pos-
sibly establishing a negative regulatory feedback loop
contributing to the termination of an autophagic response
[143]. Interestingly, several groups reported that AMPK in
turn phosphorylates ULK1 [120, 121, 140, 141]. However,
different groups mapped different phospho-acceptor sites
in the ULK1 amino acid sequence. Together with the
proteomic screens analyzing the global nutrient-dependent
ULK1 phosphorylation described above, a rather complex
picture of the ‘‘ULK1 phospho-barcode’’ evolves. The
different identified phospho-sites are summarized in sup-
plemental Table 1 and reviewed in Wong et al. and Alers
et al. [42, 45]. However, three ULK1 phospho-sites appear
to be of particular interest, since they were reported by
three or more independent groups, i.e., S556, S638, and
S758 of human ULK1 sequence [45]. The identification of
different sites by different groups already emphasizes that
the AMPK-dependent regulation of the ULK1 complex is
far from being completely characterized. However, it has
been stated that the function of AMPK in autophagy is
rather a ‘‘fine-tuning’’ than an ‘‘on–off switch’’ [45].
Apparently, mTOR, AKT, AMPK and presumably
additional kinases (see prediction in [120]) contribute to
the regulation of the ULK1–ATG13–FIP200–ATG101
complex. It is conceivable that these phosphorylation
processes depend on different factors, i.e., cell type or
autophagic stimulus. Additionally, there appear to exist
significant differences between metazoan lineages in the
regulation of the ULK kinase complex. Chang and Neufeld
reported the regulation of this complex in D. melanogaster
in parallel to the works on the mammalian complex.
Interestingly, they reported common and divergent aspects.
Like for the mammalian system, ATG13 is essential for
starvation-induced autophagy, the ATG1–ATG13 interac-
tion is independent of the nutrient status, and ATG13 is
required for the autophagy-promoting function of ATG1
[144]. In contrast to the mammalian system, ATG13 is
hyperphosphorylated under starvation conditions, indicat-
ing that the ATG13 phospho-status might be more
dependent on ATG1 than on TOR in D. melanogaster.
Furthermore, the authors demonstrated that ATG13 over-
expression blocks autophagy and that TOR associates with
ATG1/ATG13 independently of nutrient supply.
Next to the diversity among different species, different
cell types and different autophagy-inducing stimuli, the
complexity of this regulatory system is even increased by
two additional aspects: (1) the action of phosphatases and
(2) ULK1-dependent feedback signaling targeting the
upstream kinases. It can be assumed that phosphatases
contribute to the dephosphorylation of the mTOR-sites in
ULK1 and ATG13, respectively [45]. Notably, the direct
interaction between ULK1 complex components and pro-
tein phosphatases has been documented. For example,
UNC-51 interacts with the protein phosphatase 2A (PP2A)
in C. elegans, and FIP200 harbors a docking motif for
protein phosphatase 1 (PP1) [100, 145]. However, the
dephosphorylation of specific sites by specific phos-
phatases has not been reported yet. Generally, the
phosphatase inhibitor okadaic acid is viewed as inhibitor of
autophagy [45, 146–149]. Furthermore, PP2A has already
been implicated in the regulation of autophagic processes,
both as positive and negative regulator [65, 146, 148, 150].
However, it should be noted that PP2A enzymes fulfill
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multiple cellular functions with several different interact-
ing proteins, and the involvement of additional or more
selective phosphatases in the regulation of autophagy is
currently being intensely investigated.
Next to phosphatase-mediated dephosphorylation pro-
cesses, it has been postulated that feedback signaling
pathways originating from the ULK kinase complex con-
tribute to the shaping of an autophagic response.
Apparently, ULK1 can directly influence its upstream
regulators mTOR and AMPK, respectively (Fig. 2). As
described above, we were able to identify ULK1-dependent
regulation of AMPK. With regard to mTOR, it has been
well documented that Atg1/ULK1 activity affects this
kinase and its downstream signaling. In 2007, two groups
independently reported that ATG1 overexpression in D.
melanogaster negatively regulates the activity of the
(m)TOR downstream target S6K [151, 152]. Similarly,
Jung et al. observed an increased S6K phosphorylation
upon knockdown of ATG13 or ULK1 [110]. Congruent to
these observations, Chang and Neufeld reported that
ATG1–ATG13 complexes regulate TOR by modulating its
intracellular distribution and trafficking [144]. However,
these reports only indirectly show the effect of Atg1/ULK1
on mTOR activity. Two reports proved that activated
ULK1 directly phosphorylates RAPTOR and thus inhibits
mTORC1 signaling [153, 154]. Collectively, these reports
indicate that there is a close connection between mTOR-
dependent cell growth control and autophagy signaling.
Again another level of complexity is added by the fact that
the ULK1 kinase complex component FIP200 interacts
with TSC1, which is an upstream regulator of mTOR [92,
95]. Interaction of FIP200 with the TSC1–TSC2 complex
results in the inhibition of this complex, ultimately leading
to increased mTOR activity, S6K phosphorylation, and cell
growth. Taken together, it appears that ULK1 and FIP200
have opposite effects on the regulation of mTOR activity,
and future studies have to reveal the respective relative
contributions.
In general, kinase-catalyzed phosphorylations and
phosphatase-mediated dephosphorylations are the major
molecular switches regulating the autophagy-initiating
ULK1 complex. However, in the recent past alternative
post-translational modifications have been implicated in
this regulation, i.e., ubiquitination and acetylation. As
described in ‘‘Two ubiquitin-like conjugation systems in
autophagy: Atg12/ATG12–Atg5/ATG5 and Atg8/LC3–
PE’’, ubiquitination plays an essential role for cargo
recognition during selective autophagy processes. Fur-
thermore, this post-translational modification links the two
major cellular degradation pathways, i.e., the ubiquitin–
proteasome system (UPS) and selective autophagy.
Meanwhile it is well established that interference with one
pathway influences the flux through the other [155].
Finally, there are several lines of evidence that the ULK1
complex is modified by ubiquitin chains as well. Our group
observed that treatment with the deubiquitinase inhibitor
WP1130 increases ULK1 ubiquitination, and subsequently
leads to the transfer of ULK1 to cellular aggresomes and to
the parallel loss of ULK1 activity [156]. Zhou et al.
reported that nerve growth factor (NGF) can induce the
interaction of ULK1 with the NGF receptor TrkA [157].
This apparently occurs through K63-polyubiquitination of
ULK1 and binding of ULK1 to p62, which then recruits
ULK1 to TrKA receptor complexes. The study by Joo et al.
described above reporting ULK1-catalyzed phosphoryla-
tion of ATG13 at S318 indirectly confirms ULK1
ubiquitination. The authors demonstrate that the disruption
of the association between the Hsp90–Cdc37 chaperone
complex and ULK1 by the Hsp90 antagonist 17-allyl-
amino-17-demethoxygeldanamycin (17AAG) leads to
ULK1 destabilization, which can be inhibited with the
proteasome inhibitor MG132 [123]. Jiao et al. identified the
chaperone-like protein p32 as a key regulator of ULK1
stability [158]. P32 forms a complex with ULK1, and p32
depletion increased K48-linked but decreased K63-linked
polyubiquitination of ULK1, leading to proteasome-medi-
ated degradation of ULK1. Li et al. reported that the
mitochondrial outer-membrane E3 ligase MUL1 ubiquiti-
nates ULK1 and regulates selenite-induced mitophagy
[159]. Finally, Nazio et al. reported that mTOR does not
only regulate the ULK complex by phosphorylation, but
also indirectly by regulating ULK1 ubiquitination [160]. In
this study the authors show that under basal conditions
mTOR phosphorylates activating molecule in Beclin
1-regulated autophagy 1 (AMBRA1; alternatively named
autophagy/Beclin 1 regulator 1) and thus keeps it inactive.
AMBRA1 is a Beclin 1-interacting protein (see ‘‘The
PtdIns3K class III complex’’) [161]. Upon autophagy
induction, AMBRA1 enhances ULK1 kinase activity and
stability and promotes ULK1 self-association by enhancing
K63 ubiquitination of ULK1 through the AMBRA1-asso-
ciated E3-ligase tumor necrosis receptor-associated factor
6 (TRAF6) [160]. In turn, ULK1 phosphorylates AMBRA1
and thus promotes it detachment from the dynein complex
[162]. Notably, Chang and Neufeld already observed that
ATG1 and ATG13 levels were affected by TOR function in
D. melanogaster, i.e., reduced levels in cells with high
TOR activity and increased in cells with low TOR activity
[144]. Generally, it appears that the components of the
ULK1 complex are important for their mutual stabilization.
ULK1 is destabilized in cells deficient for ATG13, FIP200
or ATG101 [37, 108–110]. Similarly, FIP200 is destabi-
lized in cells deficient for ATG13 [109], and ATG13 is
reduced in ATG101-depleted cells [37, 38].
Next to ubiquitination, acetylation has been reported to
regulate autophagy. Gammoh et al. report that the histone
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deacetylase (HDAC) inhibitor suberoylanilide hydroxamic
acid (SAHA) activates autophagy via the inhibition of
mTOR and transcriptional up-regulation of LC3 expression
[163]. The authors confirmed that the SAHA-mediated
induction of autophagy depends on ULK1/2. Recently, the
direct acetylation of ULK1 was reported. Lin et al. found
that glycogen synthase kinase 3 (GSK3), which is activated
by growth factor deprivation and resulting AKT inactiva-
tion, phosphorylates and thus activates acyltransferase
TIP60 [164]. Activated TIP60 in turn acetylates and
stimulates ULK1. ULK1 acetylation presumably occurs at
K162 and/or K606, and a non-acetylatable ULK1 mutant
failed to rescue autophagy in Ulk1-/- MEFs [164]. Next to
the direct AKT-mediated ULK1 phosphorylation described
above, the GSK3–TIP60–ULK1 axis is another example
how AKT-dependent signals are transduced to the ULK1
complex independently of mTOR.
With regard to the downstream signaling machinery,
different ULK1 substrates have been reported (Fig. 2), but
frequently their exact contribution to the induction of
autophagy has still to be examined. Generally, the different
ULK1 substrates can be grouped into different categories:
(1) components of the ULK1 complex; (2) components of
the PtdIns3K complex (see ‘‘The PtdIns3K class III com-
plex’’); (3) other autophagy-related regulators and proteins,
and (4) non-autophagy-related substrates (Table 1; Fig. 2).
There likely exist several additional ULK1 substrates
which contribute to the regulation of the autophagic flux in
a phosphorylation-dependent manner. The identification
and characterization of these ULK1 substrates will greatly
enhance our understanding of autophagy signaling path-
ways. Furthermore, it has to be noted that there apparently
exist kinase-independent autophagic ULK1 functions, and
non-autophagic functions of ULK1 complex components
(reviewed in [45]) (Fig. 2). Several observations have
recently been reported to underscore the latter aspect:
nuclear ULK1 can promote cell death in response to
oxidative stress [165], ULK1 can negatively regulate the
stimulator of interferon genes (STING) pathway [166], and
ULK1 mediates expression of interferon-stimulated genes
via the p38alpha MAPK pathway [167]. Finally, also
ULK1/2-independent autophagic processes have been
reported [84, 122]. The signaling machinery upstream and
downstream of the ULK1 complex is summarized in Fig. 2.
The PtdIns3K class III complex
The yeast PtdIns3K class III complexes
Next to the ULK1–ATG13–FIP200–ATG101 complex,
another multiprotein-complex is important for the forma-
tion of autophagosomes. In yeast, the class III
phosphatidylinositol 3-kinase (PtdIns3K class III) Vps34
functions in both autophagy and sorting of vacuolar pro-
teins. Two separate Vps34 subcomplexes have been
identified to mediate these functions [168]. The autophagy-
regulating complex I contains Vps34, Vps15, Atg6
(Vps30), and Atg14. In contrast, the sorting of vacuolar
proteins is mediated by complex II, which contains Vps38
instead of Atg14 [168]. Accordingly, the unique complex-
subunits Atg14 and Vps38 regulate the intracellular local-
ization and the specific functions of these two complexes.
Atg14 mediates the localization of complex I to the PAS,
whereas Vps38 controls the localization of complex II to
endosomes [169, 170]. Recently, Araki et al. reported the
identification and characterization of yeast Atg38 [171].
The authors describe that Atg38 physically interacts with
Atg14 and Vps34 via its N terminus. The C terminus of
Atg38 mediates homodimerization, which is indispensable
for the integrity of complex I. Accordingly, it appears that
the homodimer of Atg38 functions as a linker between the
Vps15–Vps34 and Atg14–Atg6 subcomplexes, ultimately
facilitating complex I formation [171].
Mammalian PtdIns3K class III complexes
Similar to the situation in yeast, different PtdIns3K class III
complexes could be identified in mammals (reviewed in
[172–176]). The mammalian PtdIns3K class III core com-
plex consists of the catalytic subunit VPS34, the adaptor
VPS15 (p150), and Beclin 1 (ATG6) [Figs. 1 (panel 2), 3].
Beclin 1 forms the scaffold for the recruitment of additional
activators or repressors of the PtdIns3K class III complex.
Beclin 1 contains an N-terminal intrinsically disordered
region, a BCL2 homology 3 (BH3) domain, a coiled-coil
domain, and a C-terminal b-a repeated, autophagy-specific
(BARA) domain [175]. Additionally, He et al. identified
another mammalian ortholog of Beclin 1—termed Beclin
2—which functions in both autophagy and the degradation
of G protein-coupled receptors [177]. Although we address
some of the regulatory signaling pathways targeting and
established by Beclin 1, we refer readers to other excellent
reviews on this molecule [172–175].
In the recent past, three major subcomplexes have been
reported, which contain either ATG14, UV radiation resis-
tance-associated gene protein (UVRAG), or a dimer of
UVRAG and RUN domain protein as Beclin 1 interacting
and cysteine-rich containing (Rubicon) [Figs. 1 (panel 2), 3].
ATG14 (alternatively called Atg14-like, ATG14L, or
Beclin 1-associated autophagy-related key regulator, Bar-
kor) is the putative mammalian homolog of yeast Atg14
and was identified by four different groups [178–181].
Accordingly, the ATG14 containing PtdIns3K class III
complex likely represents the functional equivalent to yeast
complex I. ATG14 co-localizes with several marker pro-
teins on phagophores, indicating that this complex is
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involved in an early stage of autophagy. Furthermore,
ATG14-silencing suppresses autophagosome formation
[178–181]. It has additionally been shown that ATG14
increases VPS34 catalytic activity in a Beclin 1-dependent
manner [181]. Binding of ATG14 to Beclin 1 is mediated
via their respective coiled-coil domains [179–181]. Most
interestingly, recently it was shown that ATG14 is not only
involved in early steps of autophagosome formation, but
also in later steps. Diao et al. reported that ATG14 pro-
motes membrane tethering and fusion of autophagosomes
to endolysosomes [182]. This ATG14 function requires
ATG14 homo-oligomerization by its cysteine repeats. In
contrast, this homo-oligomerization is not required for
initial autophagosome formation [182]. Apparently,
ATG14 binds to the soluble N-ethylmaleimide-sensitive
factor attachment protein receptor (SNARE) core domain
of syntaxin 17 (STX17) and stabilizes the STX17–SNAP29
binary target-SNARE complex on autophagosomes (Fig. 3)
[182]. Previously, Itakura et al. demonstrated that the
SNARE protein Stx17 translocates to the outer
autophagosomal membrane [183]. Fusion with lysosomes
is then mediated by the interaction between autophago-
some-resident Stx17, synaptosomal-associated protein 29
(SNAP-29), and the lysosome-resident vesicle-associated
membrane protein 8 (VAMP8) [183].
In parallel, all four groups reported that the interactions
of ATG14 or UVRAG with the PtdIns3K class III core
complex are mutually exclusive, which is probably due to
their overlapping binding sites in Beclin 1 [178–181], and
accordingly it has been suggested that UVRAG represents
the mammalian Vps38 [178, 184]. Along these lines,
UVRAG was shown to primarily associate with Rab9-
positive late endosomes and partially with Rab5/Rab7-
positive endocytic compartments, and UVRAG knockdown
did not influence autophagic flux and GFP-LC3 dot for-
mation (see ‘‘Two ubiquitin-like conjugation systems in
autophagy: Atg12/ATG12–Atg5/ATG5 and Atg8/LC3–
PE’’) [178]. In contrast, UVRAG has originally been
attributed a role in autophagy signaling [185]. Furthermore,
Takahashi et al. demonstrated that Bif-1 (also termed
endophilin B1) interacts with Beclin 1 through UVRAG,
and that loss of Bif-1 suppresses autophagosome formation
[186]. In parallel, Liang et al. suggest that UVRAG-me-
diated activation of the Beclin 1/VPS34 complex
suppresses the proliferation and tumorigenicity of human
colon cancer cells, and Takahashi et al. observed that Bif-1
knockout enhances spontaneous tumor development [185,
186]. However, the interplay between UVRAG-dependent
autophagy and tumor suppression has also been contro-
versially discussed. Knævelsrud et al. demonstrated that
UVRAG mutations associated with microsatellite unstable
colon cancer do not affect autophagy [187]. Taken toge-
ther, the role of UVRAG for initial stages of autophagy
remains rather elusive. In 2008, Liang et al. reported that
UVRAG interacts with the class C Vps complex, which is a
key component of the endosomal fusion machinery [188].
This interaction promotes the GTPase activity of Rab7 and
autophagosome fusion with late endosomes/lysosomes.
The authors also showed that UVRAG enhanced endocytic
trafficking, directly supporting the above described
UVRAG localization studies. Most interestingly, the effect
on autophagosome maturation was independent of Beclin
1, indicating that UVRAG might play a dual role in
autophagy regulation: (1) in combination with Beclin 1
during autophagosome formation and (2) in combination
with C Vps/Rab7 during autophagosome maturation [188].
Finally, two of the four groups additionally identified
Rubicon as negative regulator of autophagy [179, 181]
[Figs. 1 (panel 2), 3]. Rubicon is alternatively called Beclin
1 associated RUN domain-containing protein (Baron)
[189]. Rubicon was only found in UVRAG-containing
Beclin 1/VPS34-complexes, but not in ATG14-containing
ones. Furthermore, Rubicon knockdown also affected
rather autophagosome maturation and endocytic trafficking
[179, 181]. However, Zhong et al. observed that Rubicon
inhibits VPS34 kinase activity only in the absence of
Beclin 1 overexpression, suggesting that the negative reg-
ulatory role exerted by Rubicon is Beclin 1-independent
[181]. Supporting this notion, it has been speculated that
Rubicon interferes with pro-autophagic Rab GTPases via
its RUN domain, and that sequestering of Rubicon by
Beclin 1 would vice versa promote autophagy [172]. Cur-
rently, the dynamics of the above described complexes are
intensively being investigated.
Recently, the putative mammalian counterpart of yeast
Atg38 has been identified and independently reported by
three different groups, which is named nuclear receptor
binding factor 2 (NRBF2) [Figs. 1 (panel 2), 3]. Two groups
reported that NRBF2 positively regulates autophagy,
whereas one group observed autophagy-suppressing effects
[190–192]. Accordingly, the autophagy-regulating capabil-
ity of NRBF2 is not entirely clarified. Of note, NRBF2 was
originally identified as interaction partner of nuclear recep-
tors [193, 194]. Similar to its effect on autophagy, both
activating and repressing effects of NRBF2 on nuclear
receptor signaling have been reported [193, 194].
Baskaran et al. reported the structure of the ATG14-
containing PtdIns3K complex as determined by single-par-
ticle electron microscopy [195]. It appears that the complex
is V-shaped, with VPS15 at the base of the V and serving as
bridge for VPS34 and the ATG14/Beclin 1 subcomplex.
Beclin 1-interacting proteins
Next to the stable binding of ATG14, UVRAG and Rubi-
con to Beclin 1, multiple cellular and viral Beclin
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1-interacting proteins have been identified which bind
rather transiently or specifically under certain conditions
(reviewed in [172–175]) (Fig. 3). In the following, we
would like to focus on the association of Beclin 1 with
AMBRA1 and viral and cellular BCL2 homologs. How-
ever, additional Beclin 1-interacting proteins include
EGFR [196], estrogen-receptor [197], FYVE-CENT [198],
HMGB1 [199, 200], MyD88/TRIF [201], nPIST [202],
PINK1 [203], Rab5 [204], SLAM [205], survivin [206],
and VMP1 [207], or the viral proteins HIV NEF [208],
HSV-1 ICP34.5 [209], and the influenza virus M2 protein
[210].
AMBRA1 is a scaffolding protein with a molecular
mass of *130 kDa [161]. Next to the above described
regulation of ULK1, AMBRA1 itself is regulated by
ULK1-dependent phosphorylation (see below) (Fig. 3). A
recent study by Fimia and colleagues showed that the
interaction between AMBRA1 and Cullin E3 ubiquitin
ligases regulates the dynamics of autophagic responses
[211]. Under fed conditions, Cullin-4 binds to AMBRA1
and reduces its abundance. Under pro-autophagic condi-
tions, ULK1 phosphorylates AMBRA1, leading to its
dissociation from Culin-4. Stabilized AMBRA1 in turn can
bind to Cullin-5, which leads to the accumulation of the
mTOR-inhibitory protein DEPTOR. Under prolonged
autophagic conditions, Cullin-4 reassociates with
AMBRA1, leading to its degradation and the termination of
the autophagic response [211]. However, AMBRA1 is not
only involved in bulk autophagy processes, but also in
mitophagy, cell death, cell proliferation, and development
(reviewed in [212–214]). Of note, Cianfanelli et al. recently
reported that AMBRA1 regulates the dephosphorylation
and degradation of the proto-oncogene c-Myc via PP2A
[215].
The association between Beclin 1 and viral and cellular
BCL2 homologs establishes a direct connection between
apoptosis and autophagy signaling pathways [216–224]
(Fig. 3). Beclin 1 was originally identified as BCL2-inter-
acting protein by a yeast-two-hybrid screen [219]. The
functional relevance of this interaction has been described
by Pattingre et al. in 2005 [222]. They showed that BCL2
can inhibit starvation-induced and Beclin 1-dependent
autophagy. This has been confirmed for viral BCL2 pro-
teins [216, 218, 222, 223]. The BH3 domain of Beclin 1
binds to the hydrophobic BH3-binding cleft of BCL2 [217,
220, 221, 225]. Although the interaction between Beclin 1
and BCL2 inhibits autophagy induction by nutrient depri-
vation, Beclin 1 does not suppress the anti-apoptotic
function of BCL2, as would be expected from ‘‘classical’’
BH3-only proteins [226].
Fig. 3 Signaling machinery upstream and downstream of the PtdIns3K
class III complex. The PtdIns3K class III core complex consists of the
catalytic subunit VPS34, the adaptor VPS15 (p150), and Beclin 1
(ATG6). Beclin 1 binds to additional regulatory proteins, including
ATG14, NRBF2, UBRAG, Rubicon, AMBRA1, BCL2, and several
others (reviewed in [172–175]). Furthermore, there exists consider-
able crosstalk between the ULK1-complex and the PtdIns3K class III
complex (for details see ‘‘The PtdIns3K class III complex’’). ULK1
phosphorylates Beclin 1, AMBRA1, and VPS34. In turn, AMBRA1
regulates ULK1 stability and activation. Next to ULK1 itself, several
ULK1-regulating kinases—such as mTORC1, AMPK, and AKT—
also regulate the PtdIns3K class III complex. The product of the
PtdIns3K class III catalytic activity is phosphatidylinositol 3-phos-
phate (PtdIns3P) (red circles). PtdIns3P then recruits the downstream
effectors DFCP1 and proteins of the WIPI-family. For simplicity, the
mutually exclusive interactions of ATG14 or UVRAG with Beclin 1
are shown within one complex
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The interaction between Beclin 1 and BCL2 is regulated
by several stimuli, including competitive binding, self-as-
sociation, phosphorylation, or ubiquitination [174]. The
Beclin 1 BH3 domain might be competitively displaced by
other BH3-only proteins or by BH3 mimetics, e.g.,
ABT737 [220, 225, 227]. Alternatively, membrane-an-
chored receptors or adaptors, e.g., IP3Rs or toll-like
receptor-associated Myd88/TRIF, might induce the dis-
ruption of the Beclin 1-BCL2 interaction [173]. Finally, it
has also been reported that reactive oxygen species pro-
mote cytosolic translocation of high mobility group box 1
(HMGB1), where it interacts with Beclin 1 and thus dis-
places BCL2 [200]. It has also been discussed that Beclin
1-homo-oligomerization might provide a scaffold for fur-
ther protein–protein interactions and displacement of
BCL2 proteins [174]. Additionally, post-translational
modifications of both interacting proteins might modulate
the Beclin 1-BCL2 interaction. Interestingly, both compo-
nents serve as phospho-acceptor proteins. Zalckvar et al.
reported that the death-associated protein kinase (DAPK)
phosphorylates Beclin 1 at T119, which is located within
the BH3 domain [228]. In turn, BCL2 might be phospho-
rylated by the mitogen-activated protein kinases ERK and
JNK, respectively. Wei et al. reported that JNK phospho-
rylates T69, S70 and S87 within the non-structured loop
between BH3 and BH4 of BCL2 [224]. Next to the direct
displacement of BCL2 by HMGB1 described above, it has
been suggested that HMGB1 promotes the activation of
ERK1/2, resulting in the ERK1/2-mediated phosphoryla-
tion of BCL2 and its dissociation from Beclin 1 [200].
Interestingly, it has been reported that viral BCL2 proteins
inhibit autophagy more effectively than cellular BCL2
proteins. This has been explained by either a stronger
affinity of viral BCL2 proteins to Beclin 1 or the fact that
viral BCL2 orthologs lack the JNK-dependent phosphory-
lation sites described above [218, 223, 224, 229]. It appears
that the BCL2-dependent blockade of autophagy might be
a viral strategy to ensure latency. Finally, it was demon-
strated that K117 within the BH3 domain of Beclin 1 is a
major ubiquitination site [230]. Accordingly, the authors
speculate that TRAF6-mediated K63-linked ubiquitination
at this site influences the association between Beclin 1 and
BCL2.
The interaction between BCL2 and Beclin 1 occurs both
at the mitochondrion and at the ER, and both mitochon-
drion- and ER-targeted BCL2 reduce LC3-II accumulation
induced by overexpression of Beclin 1 [231]. However,
starvation-induced autophagy is most efficiently inhibited
by ER-localized BCL2 [222, 231]. In 2009, Vicencio et al.
reported the identification of a trimeric complex consisting
of IP3Rs, Beclin 1 and BCL2 [232]. Apparently IP3Rs
facilitate the interaction between Beclin 1 and BCL2, thus
indirectly impairing autophagy. Upon IP3R inhibition, this
trimeric complex dissociates and autophagy is induced.
The authors further suggest that the Ca2? channel function
of the IP3Rs is not contributing to the autophagy-inhibitory
effect [232]. However, this has been challenged by other
groups [233, 234]. For example, in DT40 cells deficient for
all three IP3Rs, association between Beclin 1 and BCL2 is
not affected [235]. Notably, Khan et al. state that the
absence of IP3Rs in the triple-knockout DT40 cells results
in higher levels of basal autophagy, which would confirm
the results by Vicenco et al. However, reconstitution with a
functionally inactive D2550A IP3R mutant did not result in
a suppression of the autophagic flux, indicating that the
Ca2? channel function of IP3Rs is important for the regu-
lation of autophagy [235]. Along these lines, Decuypere
et al. suggest that IP3R-mediated Ca
2? signaling and
autophagy induction are indeed two interrelated processes
[236]. They showed that IP3Rs are sensitized upon star-
vation, and that this sensitization depends on Beclin 1. In
their model, Beclin 1 shuttles from BCL2 to the ligand
binding domain of the IP3Rs upon starvation, indirectly
confirming the importance of ER-localized BCL2 to
modulate autophagy (see above). Next to IP3Rs, another
ER-localized transmembrane protein has been implicated
in the regulation of the Beclin 1-BCL2 association. Chang
et al. reported the identification of the nutrient-deprivation
autophagy factor-1 (NAF-1), and its requirement for BCL2
at the ER to functionally antagonize Beclin 1-dependent
autophagy [237]. Additionally, NAF-1 also interacts with
IP3Rs. Interaction with IP3Rs was also shown for different
BCL2 family members (reviewed in [233, 234, 238–240].
Future studies will have to further elucidate the interplay
between IP3Rs, other ER-localized proteins, BCL2 family
members, and Beclin 1. However, a central role for the
regulation of autophagy has also been attributed to mito-
chondria-localized BCL2. Strappazzon et al. showed that
the positive autophagy regulator AMBRA1 preferentially
binds to the mitochondrial pool of BCL2. Upon starvation,
AMBRA1 is released and competes with BCL2 for binding
to mitochondria- or ER-localized Beclin 1 [241]. Taken
together, it appears that BCL2 proteins interfere with
Beclin 1 function by at least two different ways, i.e.,
directly by binding of Beclin 1 or indirectly by binding to
the positive regulator AMBRA1 [241, 242].
To date, different models have been brought up to
explain the direct BCL2-dependent inhibition of Beclin 1
[243]. Pattingre et al. detected that BCL2 overexpression
interferes with the formation of the Beclin 1–VPS34
complex [222]. Furthermore, they confirmed that the
functional activity of the PtdIns3K class III complex is
reduced. Recently, Wei et al. reported that mitogen-acti-
vated protein kinase-activated protein kinase 2
(MAPKAPK2) and MAPKAPK3 positively regulate star-
vation-induced autophagy by phosphorylating Beclin 1 at
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serine 90 [244]. The authors suggest that BCL2 can block
this phosphorylation and thus inhibits autophagy. Noble
et al. demonstrated that Beclin 1 forms a dimer in solution,
which is bound by BCL2 proteins. UVRAG disrupts this
Beclin 1 dimer interface and thus UVRAG–Beclin 1 het-
erodimers are assembled, which presumably cause the
activation of autophagy. In turn, BCL2 proteins reduce the
affinity of UVRAG for Beclin 1 and thus stabilize Beclin 1
homodimers [245]. Generally, only ATG14, UVRAG and
Rubicon are stably associated with the PtdIns3K class III
core complex [172]. Accordingly, the unstable or transient
interaction of Beclin 1 with Bcl-2 proteins allows the
dynamic regulation of autophagic processes.
Crosstalk between ULK1 and PtdIns3K class III complexes
and downstream effectors of PtdIns3P
It appears that there is a direct crosstalk between the
autophagy-initiating ULK1 protein kinase and VPS34/Be-
clin 1 lipid kinase complexes (Figs. 2, 3, 4). Russell et al.
demonstrated that ULK1 directly phosphorylates Beclin 1
at S15 and thereby enhances the activity of the ATG14-
containing VPS34 complexes (Fig. 3) [246]. This is further
supported by the observation that ULK1 also phosphory-
lates AMBRA1 (Fig. 3) [162]. This phosphorylation
triggers the dissociation of AMBRA1 and the associated
PtdIns3K class III complex from dynein light chains 1/2.
The resulting relocalization of this complex to the ER
allows for the nucleation of autophagosomes [162]. Con-
sidering the results by Nazio et al. described in ‘‘The Atg1/
ULK1 complex’’, there apparently exists a mutual regula-
tory circuit involving ULK1 and AMBRA1, i.e., AMBRA1
regulates the stability and kinase activity of ULK1 by
controlling its ubiquitination, and in turn ULK1 regulates
the association of AMBRA1 with the cytoskeleton via
phosphorylation. Recently, Egan et al. reported the direct
phosphorylation of VPS34 by ULK1 [124].
There is not only crosstalk between the ULK1 complex
and the VPS34/Beclin 1 complex, but these two autophagy-
initiating complexes also share common upstream regula-
tors, such as AMPK, mTOR and AKT (Fig. 3). AMPK
phosphorylates both Beclin 1 and VPS34, respectively
[247]. Apparently, AMPK inhibits the non-autophagy
VPS34 complex by phosphorylating T163/S165 in VPS34,
but activates the pro-autophagy VPS34 complex by phos-
phorylating Beclin 1 at S91/S94 [247]. Additionally,
mTORC1 inhibits the PtdIns3K activity of the ATG14-
containing VPS34 complex by phosphorylating ATG14
[248]. Finally, AKT directly phosphorylates Beclin 1 and
inhibits autophagy by the formation of a phospho-Beclin
1/14-3-3/vimentin intermediate filament complex [249],
and active EGFR binds Beclin 1, leading to its multisite
tyrosine phosphorylation [196]. This phosphorylation
decreases VPS34 catalytic activity, thereby establishing a
direct link between oncogenic receptor tyrosine kinases
and the autophagy machinery.
The product of the PtdIns3K class III catalytic activity is
phosphatidylinositol 3-phosphate (PtdIns3P). This lipid
then recruits further downstream effectors such as DFCP1
(see ‘‘Types of autophagy and morphology’’) and proteins
of the Atg18/WIPI-family (see ‘‘Atg18/WIPI proteins and
Atg2/ATG2’’) (Fig. 3). This has been confirmed by two
studies, showing that knockdown of ATG14 or VPS34
leads to the disappearance of DFCP1- or WIPI1-positive
puncta, respectively [250, 251]. However, it has been
observed that autophagy might also be induced indepen-
dently of VPS34/Beclin 1 [252, 253]. On the one hand this
might be explained by alternative cellular sources of
PtdIns3P, e.g., through class II PtdIns3Ks [254] or class I
PtdIns3Ks in combination with the lipid phosphatases
SHIP and INPP4 [255]. On the other hand, Rubinsztein and
coworkers recently demonstrated that PtdIns5P can regu-
late autophagy via PtdIns3P effectors [256].
Atg9/ATG9A
Atg9 is the only multi-spanning transmembrane protein
among the Atgs (reviewed in [257, 258]) (Fig. 1, panel 3).
In yeast, it was demonstrated that Atg9 concentrates in
clusters that comprised vesicles and tubules, and that these
compartments contribute to the de novo formation of the
PAS [259]. Yamamoto et al. reported that single-mem-
brane and Golgi-derived Atg9-vesicles with a diameter of
30–60 nm (containing approximately 30 Atg9 molecules)
assemble to the PAS upon starvation [260]. These vesicles
apparently become part of the phagophore and the outer
autophagosomal membrane. Upon autophagosome com-
pletion, Atg9 clusters are recycled back to the cytoplasm
[260]. It has been shown earlier that Atg9 is recruited to the
PAS by Atg17 and that Atg9 cycling depends on Atg1–
Atg13 and Atg18–Atg2 complexes, respectively [67, 261].
Additionally, several groups identified proteins that are
involved in Atg9 trafficking, including Atg11, Atg17,
Atg23, Atg27, Trs85, Arp2/3 and actin [262]. Recently,
Backues et al. identified a core minimal machinery nec-
essary and sufficient for the trafficking of Atg9 to the PAS,
i.e., Atg11, Atg19, Atg23 and Atg27 [262]. Finally, Suzuki
et al. recently reported that the Atg13 HORMA domain
(described in ‘‘The Atg1/ULK1 complex’’) can interact
with Atg9 and thus recruits Atg9 vesicles during
autophagosome formation (Fig. 4) [72]. As described
above, Atg1-dependent phosphorylation of Atg9 is appar-
ently important for the efficient recruitment of Atg8 and
Atg18 to the site of autophagosome formation (Fig. 4) [68].
However, it has also been noted that the Atg9-positive
vesicles described above are unlikely a major supplier of
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lipids for autophagosome biogenesis and thus likely pos-
sess an additional important function for autophagosome
biogenesis [260].
In 2006, it has been reported that the mammalian Atg9
ortholog ATG9A (also referred to as mAtg9 or Atg9L1) is
localized in the trans-Golgi network and in early, late and
recycling endosomes [263, 264]. Upon starvation, ATG9A is
redistributed to peripheral, endosomal membranes positive
for the autophagosomal marker GFP-LC3 (see ‘‘Two ubi-
quitin-like conjugation systems in autophagy: Atg12/
ATG12–Atg5/ATG5 and Atg8/LC3–PE’’) [264]. Like in
yeast, this redistribution depends on the mammalian Atg1
homolog ULK1 [264]. An ATG9A compartment in mam-
mals has been proposed which is similar to the one observed
in yeast [263]. The authors suggest that ATG9A resides on a
distinct tubular-vesicular compartment, and that this
‘‘ATG9A reservoir’’ continuously emanates from vacuolar
recycling endosome-like structures by tubulation. They
observed that subcellular ATG9A localization is regulated
by ULK1 and WIPI2. However, ULK1 and WIPI2 are not
required for the recruitment of ATG9A to early DFCP1-
positive omegasomes [263]. Similar observations were pre-
viously made by other groups. For example, it has been
demonstrated that ATG9A and ULK1 independently local-
ize to the autophagosome formation site during canonical
autophagy and Parkin-mediated mitophagy (see ‘‘Two
ubiquitin-like conjugation systems in autophagy: Atg12/
ATG12–Atg5/ATG5 and Atg8/LC3–PE’’), and that ATG9A
and ULK1 are independently recruited to Salmonella-con-
taining vacuoles during xenophagy [265, 266]. Although
ATG9A is essential for the formation of phagophores, it
appears that ATG9A only transiently interacts with
autophagosomes and does not integrate into the autophago-
somal membrane [263]. Recently, Popovic and Dikic
reported that TBC1D5 and the AP2 complex are important
novel regulators of ATG9A trafficking towards the sites of
autophagosome formation [267]. Finally, Puri et al. reported
that ATG9A localizes on the plasma membrane in clathrin-
coated structures and is internalized through early and then
recycling endosomes [268]. Notably, the authors describe
that ATG16L1 (see ‘‘Two ubiquitin-like conjugation sys-
tems in autophagy: Atg12/ATG12–Atg5/ATG5 and Atg8/
LC3–PE’’) is also internalized by clathrin-mediated endo-
cytosis but via different clathrin-coated pits. The ATG9A-
and ATG16L1-containing vesicles then ‘‘meet’’ in recycling
endosomes in a VAMP3-dependent manner [268].
Atg18/WIPI proteins and Atg2/ATG2
The Atg18 proteins constitute the second important family
of PtdIns3P effectors (Fig. 1, panel 4). Whereas in yeast
three family members have been identified so far, i.e.,
Atg18, Atg21 and HSV2/Ygr223c, in mammals four Atg18
homologs have been isolated, i.e., WD-repeat protein
interacting with phosphoinositides 1–4 (WIPI1-4) [8, 269,
270]. DFCP1 binds to PtdIns3P via its FYVE domain,
which was named after the first four proteins shown to
contain it, i.e., Fab1, YOTB/ZK632.12, Vac1, and EEA1
[271]. In contrast, the Atg18/WIPI proteins bind to PtdIns-
3P (and PtdIns(3,5)P2) via a seven-bladed b-propeller.
Accordingly, the three yeast proteins and the four WIPIs
have been called ‘‘PROPPINs’’ [272]. These proteins are
WD40-repeat containing proteins and require an FRRG-
motif for PtdIns3P-binding [270, 273, 274]. Two groups
reported the crystal structure of yeast HSV2/Ygr223c, and
these works indicate that there are two phosphoinositide
binding sites in PROPPINS [275, 276]. Yeast Atg18 is
important for autophagy, whereas Atg21 and HSV2/
Ygr223c are rather involved in the Cvt pathway and in
micronucleophagy, respectively [8, 277–279]. In 2010,
Nair et al. reported that Atg18 and Atg21 facilitate the
recruitment of Atg8–PE to the site of autophagosome for-
mation [280]. During autophagy, Atg18 is in complex with
Atg2 [281], and it was demonstrated that autophagosome
formation can be achieved in the absence of Atg18 by
expressing engineered PAS-targeted Atg2 [282]. In mam-
mals, WIPI1 and WIPI2 share highest homology to Atg18
and have thus been reported to be involved in autophagy
[283]. During autophagosome biogenesis, WIPI1/2 colo-
calize with the Beclin 1/VPS34 complex component
ATG14, but not with the second PtdIns3P effector DFCP1
[8, 250]. It has been suggested that WIPI1/2 localize to the
phagophore, whereas DFCP1 localizes to the omegasome
[8]. Subsequently, it was demonstrated that WIPI2 posi-
tively regulates LC3-lipidation (see ‘‘Two ubiquitin-like
conjugation systems in autophagy: Atg12/ATG12–Atg5/
ATG5 and Atg8/LC3–PE’’) and thus obviously contributes
to the maturation process of omegasomes to autophago-
somes [283]. Recently, Dooley et al. demonstrated that
ATG16L1 directly binds WIPI2b (one of five WIPI2 iso-
forms) (Fig. 4) [284]. They observe that WIPI2b is a
PtdIns3P effector upstream of ATG16L1 and is required
for LC3 conjugation [284].
Two mammalian Atg2 homologs have been identified,
ATG2A and ATG2B, and their simultaneous silencing
causes a block in the autophagic flux [285]. Interestingly,
ATG2A/B also regulate lipid droplet morphology [285].
Two ubiquitin-like conjugation systems
in autophagy: Atg12/ATG12–Atg5/ATG5 and Atg8/
LC3–PE
Components of the two ubiquitin-like conjugation systems
Two ubiquitin-like conjugation systems are centrally
involved in the expansion of autophagosomes: (1) Atg12/
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ATG12–Atg5/ATG5 system and (2) Atg8/LC3-phos-
phatidylethanolamine (PE) system (reviewed in [286])
(Fig. 1, panels 5 and 6). Within these conjugation systems,
Atg12 and Atg8 represent the ubiquitin-like proteins,
which are conjugated by E1-, E2- and E3-like enzymatic
activities to Atg5 and PE, respectively. Within the first
system, Atg12 is activated by the E1-like enzyme Atg7.
Subsequently Atg12 is transferred to the E2-like Atg10 and
irreversibly conjugated to K149 (yeast sequence; corre-
sponds to human K130) of Atg5 [286–289]. The Atg12–
Atg5 conjugate interacts with Atg16, and this complex
forms a homo-oligomer [286, 290, 291]. All yeast Atgs
involved in the Atg12–Atg5 conjugation system have
mammalian counterparts with identical or similar func-
tions, including an Atg16-like protein (ATG16L1) [286,
292–295]. In yeast, this multimeric complex has a molec-
ular weight of approximately 350 kDa, and it has been
suggested that the complex consists of an Atg12–Atg5–
Atg16 tetramer [290]. In mammals, the complex eluted in
fractions corresponding to 400 and 800 kDa, indicating
that it might be composed of four or eight sets of ATG12–
ATG5–ATG16L1 [292]. However, a crystallographic study
combined with analytical ultracentrifugation experiments
revealed that yeast Atg16 forms a parallel coiled-coil dimer
[296]. The E1-like ATG7, the E2-like ATG3 and the
conjugation acceptor ATG5 are essential for autophagy,
and neonates of Atg7-/-, Atg3-/- and Atg5-/- mice die at
day 1 after birth due to the neonatal starvation period [297–
299]. Within the second conjugation system, Atg8 is acti-
vated by the common E1-like enzyme Atg7 and then
transferred to the E2-like Atg3 [286, 300]. However, prior
to Atg8 activation by Atg7, the C-terminal R117 has to be
removed by the proteolytic activity of Atg4 in order to
expose G116 [286, 301]. Interestingly, it has been
demonstrated that the Atg12–Atg5 conjugate possesses an
E3-like activity for Atg8 conjugation to PE [302, 303].
Although Atg16 is not important for efficient Atg8–PE
conjugation in vitro, it is required for Atg8–PE formation
in vivo [303]. Atg16 recruits Atg12–Atg5 to the PAS and
thus determines the site of Atg8 lipidation [15, 51]. Two
structural reports further support this link between the two
conjugation systems. First, the crystal structure of Atg12–
Atg5 indicates that Atg12 serves as binding module for the
E2-like Atg3, essentially facilitating the transfer of Atg8
from Atg3 to the PE in the membrane [304]. Second,
apparently the Atg12–Atg5 conjugate enhances the E2
activity of Atg3 by rearranging its catalytic site [305].
In the mammalian system, so far nine Atg8 orthologs
have been reported. These can be subdivided into two
families: (1) the LC3 subfamily consisting of microtubule-
associated proteins 1A/1B light chain 3A (MAP1LC3A or
briefly LC3A; two splice variants), LC3B, LC3B2, and
LC3C, and (2) the GABARAP/GATE16 subfamily
consisting of the c-aminobutyric acid receptor-associated
protein (GABARAP), GABARAPL1 (also termed ATG8L
or GEC1), Golgi-associated ATPase enhancer of 16 kDa
(GATE16, also termed GABARAPL2) and GABARAPL3
[306–315]. Additionally, four different mammalian ATG4
isoforms have been identified, i.e., ATG4A-D (also refer-
red to as autophagin-1–4) [316, 317]. LC3B is probably the
most extensively studied mammalian ATG8 protein, and it
is cleaved C-terminally of G120 within the first 6 min of
synthesis [309, 318]. ATG4-mediated cleavage of LC3
generates a cytosolic truncated LC3-I fragment of 18 kDa,
which lacks the 22 C-terminal amino acids of the pro-form
[318]. Interestingly, the different ATG4 isoforms possess
selective preferences regarding their ATG8 family sub-
strates [309, 319]. Subsequently, LC3-I is converted to the
lipidated LC3-II isoform in an E1/E2/E3-cascade similar to
the yeast system [295, 309, 320]. Accordingly, the mam-
malian ATG12–ATG5 conjugate interacts with ATG16L1,
which targets the conjugate to the phagophore [292, 321].
There the ATG12–ATG5–ATG16L1 complex exerts its
E3-like function and thus determines the site of LC3 lipi-
dation [322]. This has been supported by the observation
that forced expression of ATG16L1 at the plasma mem-
brane led to ectopic LC3 lipidation at that site [322].
Similarly to LC3 conversion, the other mammalian ATG8
family members are processed by ATG4 isoforms, form
E1- and E2-intermediates with ATG7 and ATG3, and are
targeted to the autophagosome [295, 309, 312, 320, 323].
Next to cleavage and lipidation, it has also been reported
that LC3 becomes phosphorylated. Jiang et al. observed that
T9 and T29 of LC3 can be phosphorylated by PKC [324].
However, mutations of these residues to either alanine or
aspartate/glutamate did not affect autophagy. In contrast,
Cherra et al. reported the PKA-mediated phosphorylation of
LC3 at S12, and this phosphorylation regulates the incor-
poration of LC3 into the autophagosomal membrane: the
pseudophosphorylated S12D mutant showed reduced
recruitment to autophagosomes, whereas the nonphospho-
rylatable S12Amutant exhibited enhanced puncta formation
[325]. Of note, Atg8 orthologs of yeast and D. melanogaster
lack this PKA site, and it is also absent in the mammalian
GABARAP/GATE16 subfamily [325].
Selective autophagy and autophagy receptors/adaptors
Both conjugates, i.e., ATG12–ATG5 and Atg8/LC3–PE, are
targeted to membranes during the autophagic process.
Whereas ATG12–ATG5–ATG16L1 is mainly found at the
phagophore [292, 321], Atg8/LC3–PE is present on the
autophagosomal membrane throughout the whole process of
vesicle biogenesis. The exact function of this ‘‘decoration’’
of the autophagosomal membrane is still intensely being
investigated. In 2007, Nakatogawa et al. reported that Atg8
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mediates the tethering and hemifusion of liposomes in vitro,
and the authors suggested that this function contributes to
the expansion of the phagophore in vivo [326]. Additionally,
it has been reported that the amount of Atg8 determines the
size of autophagosomes [327]. Generally it is tempting to
speculate that the different Atg8 family proteins are selec-
tively incorporated into the autophagosomal membrane
depending on the autophagic stimulus, the step during the
autophagic flux, or the cargo to be degraded. The latter two
aspects are supported by two works. The first study proposes
that LC3 proteins are rather involved in the elongation of the
autophagosomal membrane, whereas GATE-16/
GABARAP proteins function during the later stages of
autophagosome maturation [314]. The second work reports
that LC3C is required for efficient xenophagic clearance of
Salmonella typhimurium [328]. This observation leads over
to the best studied function of ATG8 family proteins, i.e.,
enabling the cell to differentially handle the cargo during
selective autophagy. In recent years, a new class of cargo-
recognition receptors has been identified and characterized,
and they have been termed autophagy receptors [329–334].
These autophagy receptors are centrally involved in the
recognition of cargo during selective autophagy processes,
e.g., mitophagy or xenophagy. In 2005, Bjørkøy et al. dis-
covered that p62 (alternatively called sequestosome 1,
SQSTM1) forms protein aggregates which are degraded by
autophagy [335]. In turn, inhibition of autophagy resulted in
an increase of p62 protein levels. The authors suggested that
p62 links polyubiquitinated proteins to the autophagic
machinery via LC3. The same group could demonstrate that
p62 directly binds to Atg8/LC3 [336]. They found an evo-
lutionarily conserved 22-residue amino acid sequence
within p62 which mediates the binding to LC3. This region
was dubbed the LC3-interacting region (LIR), LC3 recog-
nition sequence (LRS), or Atg8-family interacting motif
(AIM), respectively [336–338]. Johansen et al. compiled a
sequence logo from 25 different LIR motifs from 21 dif-
ferent proteins. It appears that LIR motif contains eight
amino acids and is X-3X-2X-1W0X1X2L3 [330]. In this
sequence,Wmight be replaced by F or Y (aromatic residue),
L by I or V (large, hydrophobic residue), and acidic amino
acids are frequently found in the X-3X-2X-1 positions. This
suggestion was later confirmed by a compilation of 26
published LIR sequences [339]. Next to the LIR, p62 possess
an ubiquitin-associated (UBA) domain and a Phox and
Bem1p (PB1) domain, through which p62 can homo-
oligomerize or bind to protein kinases. Accordingly,
Johansen et al. proposed three required features of
autophagy receptors: (1) existence of a LIR motif, (2)
specific recognition of cargo, and (3) ability to polymerize
[330]. Interestingly, Itakura et al. demonstrated that the
targeting of p62 to the autophagosome formation site
depends on the ability to self-associate, but not on LC3 or
any other classical ATG [340]. The authors suggest that
subsequently p62 oligomers are incorporated into
autophagosomes in an LC3-dependent manner. In addition
to p62, several additional autophagy receptors have been
identified to date, including neighbor of breast cancer 1
(NBR1), optineurin (OPTN), nuclear domain 10 protein 52
(NDP52; alternatively termed Ca2?-binding and coiled-coil
domain-containing protein 2, CALCOCO2), Toll interact-
ing protein (TOLLIP), or cellular Casitas B-lineage
lymphoma (c-Cbl) [341–345] (reviewed in [329–334, 346]).
Next to autophagy receptors which interact with both
ubiquitin and LC3, other proteins have been identified
which contribute to selective autophagy processes. These
include proteins which interact with ubiquitin (e.g.,
HDAC6), which bind to LC3 (e.g., NCOA4, BNIP3, Nix,
FUNDC1, BCL2L13, or FAM134B), or which indirectly
associate with ubiquitinated proteins or LC3 (e.g., Alfy,
BAG3, or Tecpr1) (reviewed in [333, 346]). FAM134B is
presumably the mammalian ortholog of yeast Atg40 and is
involved in ER-phagy [347]. Nuclear receptor coactivator 4
(NCOA4) was shown to mediate the delivery of ferritin to
lysosomes [348]. BNIP3, Nix, FUNDC1 and BCL2L13 are
mitochondrial proteins and are involved in the removal of
mitochondria from maturing reticulocytes, during hypoxia-
induced mitophagy, or induce mitochondrial fragmentation
and mitophagy. In contrast, mitophagy of damaged mito-
chondria involves the action of PTEN-induced putative
protein kinase 1 (PINK1) and the E3 ubiquitin ligase Par-
kin (reviewed in [349–351]). It has been suggested that
Parkin hyper-ubiquitinates targets in the outer mitochon-
drial membrane, which are then recognized by autophagy
receptors. The Parkin-dependent ubiquitylome in response
to mitochondrial depolarization has been reported, and the
authors found depolarization-dependent association of
Parkin with numerous targets of the mitochondrial outer
membrane, autophagy receptors, and the proteasome [352].
Interestingly, the autophagy receptors p62, NDP52, and
Tax1BP1 were found to be depolarization-dependently
ubiquitinated and associated with Parkin [352]. However,
the involvement of p62 in damage-induced mitophagy is
controversially discussed (reviewed in [349–351]). It
appears that p62 is recruited to ubiquitinated cargo at
damaged mitochondria and contributes to mitochondrial
clustering, but its exact contribution to the mitophagic
process itself awaits further clarification. Next to p62, it has
been reported that optineurin is an autophagy receptor for
damaged mitochondria in parkin-mediated mitophagy
[353]. During the last 2 years additional mechanistic
details have been deciphered with regard to PINK1/Parkin-
dependent mitophagy. Activated PINK1 phosphorylates
both Parkin and ubiquitin at S65, and these phosphoryla-
tions relieve the autoinhibition of Parkin, leading to an
active phospho-ubiquitin-dependent E3 ligase and a
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feedforward signaling amplification loop [354–356].
Recently, Lazarou et al. suggested that NDP52 and opti-
neurin are directly recruited to damaged mitochondria by
PINK1-generated phospho-ubiquitin and thus support both
Parkin-dependent and -independent mitophagy [357].
Generally, the interplay between these different routes of
mitophagy (i.e., BNIP3/NIX/FUNDC1/BCL2L13 and
PINK1/Parkin) is not entirely clarified. Furthermore, there
likely exist additional pathways like the cardiolipin-medi-
ated removal of injured mitochondria in neurons or the
recently reported AMBRA1-dependent mitophagy, which
can be both Parkin-dependent and -independent but
requires LC3-binding (Fig. 4) [358, 359]. So far, the
complementarity or even redundancy of the different
mitophagy mechanisms remains elusive.
Future studies will have to delineate how ubiquitin
signals regulate the selection of autophagy cargo. It is
likely that additional autophagy receptors will be identi-
fied in the future, and next to ‘‘classical’’ autophagy
receptors other forms of receptors will emerge. For
example, cargo recognition by Tecpr1 is ubiquitin-inde-
pendent. Instead, Tecpr1 binds to ATG5 and WIPI2 [139,
360]. Additionally, post-translational modifications such
as phosphorylation might influence the function of
autophagy receptors and presumably the cargo selection
process, as shown for p62 and optineurin [345, 361, 362].
Finally, recently it has been demonstrated that N-terminal
arginylation of the ER chaperone BiP is induced by
cytosolic misfolded proteins [363]. Furthermore, cytosolic
arginylated BiP binds to both the misfolded proteins and
the ZZ domain of p62, leading to p62 aggregation,
increased p62-binding to LC3, and targeting to
autophagosomes [363]. Next to autophagy receptors, the
term autophagy adaptor has been established [346].
Autophagy adaptors are ATG8 family-binding proteins
which serve as anchors for the autophagy signaling
machinery in order to facilitate autophagosome initiation,
elongation, transport and fusion to lysosomes [346].
Accordingly, autophagy adaptors include components of
the ULK1-complex (see below) and the Beclin 1/VPS34-
complex, proteins of the ubiquitin-like ATG5/ATG12 and
Atg8/LC3 conjugation systems, and proteins of the
autophagosome–lysosome fusion machinery [346].
Recently, Wollert and colleagues described that Atg8–PE
directly recruits Atg12–Atg5 conjugates through a non-
canonical AIM in Atg12 (Fig. 4) [364]. Then Atg16 ini-
tiates a membrane scaffold by crosslinking Atg8–PE/
Atg12–Atg5 complexes into a 2D meshwork [364]. The
authors postulate that cargo receptors compete with
Atg12–Atg5 for Atg8–PE binding, thus explaining why
Fig. 4 The ATG ‘‘spiderweb’’.
This scheme depicts the crosstalk
between the six ATG signaling
modules described in this review.
The adjacent positioning of
proteins within the single modules
does not necessarily reflect direct
interactions of the components.
Lines can indicate both interaction
and/or phosphorylation (by
ULK1). Crosstalks identified for
yeast orthologs are indicated by
red lines
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Atg8–PE can function both as a membrane scaffold and as
cargo receptor [364].
Apparently there is also crosstalk between the ULK1
complex and components of the ubiquitin-like conjugation
systems (Figs. 2, 4). Three articles focusing on the interac-
tion between Atg1/ULK1 and Atg8 family proteins have
been published in the recent past. Notably, the association of
ULK1withGate16 andGABARAPwas already described in
the year 2000 by Okazaki et al., and they mapped the inter-
action sites to ULK1 amino acids 287–416 [365]. In the first
of the three mentioned publications, Kraft et al. showed that
Atg8 binds to a LIRwithinAtg1 [57]. They suggest that Atg8
targets Atg1 to autophagosomes where it might contribute to
autophagosomematuration and/or their fusion to lysosomes.
Additionally, the Atg8–Atg1 interaction targets the Atg1
complex for vacuolar degradation. The authors also
demonstrated that mammalian ULK1 harbors a LIR and that
ULK1 interacts with GABARAP, Gate16 and LC3B, thus
directly confirming the results previously obtained by Oka-
zaki et al. Similar to their observations in yeast, ULK1 was
LIR-dependently targeted to autophagosomes [57]. In the
second manuscript, Nakatogawa et al. independently con-
firmed the association between yeast Atg8 and Atg1 [366].
Mutation of the Atg8 family interactingmotif (AIM) of Atg1
abolishes Atg1 transport to and degradation in vacuoles.
Interestingly, AIM mutation caused a significant defect in
autophagy, but did not affect PAS organization or the initi-
ation of phagophore formation [366]. This result suggests
that there are indeed two functions of Atg1/ULK1: (1) ini-
tiation of phagophore formation and (2) autophagosome
expansion/maturation and/or fusion to vacuoles/lysosomes.
Finally, the ULK1 LIR domain (D356FVMV) was also
described by Alemu et al. [339]. Notably, they additionally
found LIR sequences within ATG13 (D443FVMI) and
FIP200 (D701FETI). Apparently, all three components of the
ULK1 complex have preferences towards the GABARAP-
subfamily of mammalian ATG8 proteins. As described
above, the GATE-16/GABARAP family was reported to
play a role in later stages of autophagy, indirectly suggesting
that theULK1 complex components have a function at a later
stage, too. Alemu et al. verified that the LIRmotif inULK1 is
required for the association of ULK1 with phagophores and/
or autophagosomes. However, in contrast to the two reports
by Kraft et al. and Nakatogawa et al., they state that ULK1 is
mainly degraded by the proteasome with only marginal
contribution from autophagy, which is in accordance to
observations made by Joo et al. [123]. Another level of
crosstalk between the ULK1 kinase complex and the ubi-
quitin-like conjugation systems was deciphered recently by
three works. Gammoh et al. and Nishimura et al. reported
that FIP200 can directly interact with ATG16L1 [94, 103].
Gammoh et al. mapped the binding site within ATG16L1 to
amino acids 229–242 and named this region FIP200-binding
domain (FBD). Importantly, deletion of the FBD does nei-
ther abolish ATG16L1-binding to ATG5 nor self-
dimerization. Expression of the FBD-deleted ATG16L1 in
the ATG16L1-negative background could not fully recon-
stitute autophagy induced by amino acid starvation or the
mTOR inhibitor Torin1 [94]. Similar results were reported
by Nishimura et al. [103]. They showed that the FIP200–
ATG16L1 interaction is independent of ATG14 or PtdIns3P,
and that the interaction is important for ATG16L1 targeting
to the phagophore. The authors narrowed down the interac-
tion domain to two regions of ATG16L1, i.e., amino acids
230–250 (roughly overlapping with the FBD reported by
Gammoh et al.) and 288–300. They additionally suggest that
the ATG12–ATG5–ATG16L1 complex and the ULK1–
ATG13–FIP200–ATG101 complex form one large unit in
the cytoplasm, which then targets the phagophore. Accord-
ingly, the authors describe their observation that ULK1 and
ATG5 are recruited to the same compartment with similar
kinetics (see ‘‘Molecular hierarchy of Atg/ATG proteins’’).
Most surprisingly, they observed a blockade of the
autophagic fluxwhen they express anATG16L1D (230–300)
mutant in Atg16l1-/- MEFs, but not when expressing the
ATG16L1 (1–230) version, which also lacks the FIP200-
interacting domain. They proposed a model involving a self-
inhibitory role for the C-terminal WD-repeat domain of
ATG16L1. If this domain is deleted, the N-terminal half of
ATG16L1 uncoordinatedly targets membranes, including
the autophagosome formation site [103]. Finally, Lim et al.
recently reported that ULK1 phosphorylates S405 and S409
within the ubiquitin-association (UBA) domain of p62 [361].
The S409 phosphorylation increases the binding affinity of
p62 to ubiquitin. Collectively, the observations described
above support a role of the ULK1 complex not only for
autophagy initiation, but also for later steps of the autophagic
cascade.
ATG8 proteins and monitoring autophagy
The detection of PE-conjugated GFP-LC3 at the
autophagosomal double-membrane by confocal laser
scanning microscopy is an established method for the
analysis of autophagic processes [367]. This method has
even been optimized by using the tandem fluorescence
mRFP-EGFP-LC3 fusion protein [368]. Upon fusion of
mature autophagosomes with lysosomes, the resulting low
pH quenches the GFP fluorescence and accordingly
autolysosomes can be detected as RFP-only structures
[368]. By this means, the autophagic flux can be monitored.
An improved tandem fluorescence-tagged mTagRFP-
mWasabi-LC3 has been described by Zhou et al. [369].
Alternatively, the conjugation of LC3 to PE can also be
detected by immunoblot analysis, since the lipidated
LC3-II exhibits a slightly increased mobility in SDS-PAGE
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compared to the unlipidated LC3-I. In contrast to the
Atg12/ATG12–Atg5/ATG5 conjugate, Atg8/LC3 proteins
can be deconjugated from PE by the activity of Atg4/ATG4
isoforms [301]. It appears that this deconjugation is
important to maintain an appropriate supply of Atg8/LC3
at early stages of autophagy, and to facilitate the matura-
tion into fusion-capable autophagosomes at later stages
[370]. Although the lipidation of LC3 is the basis for
several standard detection methods of autophagy, several
caveats have to be considered. Apparently, LC3 lipidation
can occur in an autophagy-independent manner (reviewed
in [371]). LC3-II can be detected in cells in which certain
ATGs are deleted, e.g., in Fip200-/- MEFs [82], Becn1-/-
ES cells [134], BECN1-/- DT40 (own unpublished
observation), Ulk1-/- MEFs [83, 110], Ulk1/2-/- MEFs
[84, 372], or in cells in which certain ATGs are severely
reduced by RNAi, e.g., Beclin 1 [134, 373], ATG13 [107,
109, 110], ULK2 [110], ATG14 [178], or VPS34 [178]. A
similar observation was made for the yeast system. Atg8–
PE was detected in yeast strains deficient for Atg1, Atg2,
Atg6, Atg9, Atg13, Atg14, Atg16, or Atg17, and slightly
also in strains deficient for Atg5 or Atg12 [15]. These
observations indicate that LC3 is lipidated under conditions
in which the autophagic flux is inhibited. Vice versa, a
recent report by Szalai et al. suggests that autophagy of
cytoplasmic bulk cargo does not require LC3 [374].
Finally, in 2007 Sanjuan et al. described that particles
that engage TLRs on macrophages while they are phago-
cytosed trigger LC3 recruitment to the phagosome [375].
This processed was termed LC3-associated phagocytosis
(LAP). LAP requires ATG5 and ATG7 and is preceded by
Beclin 1 recruitment and PtdIns3K kinase activity [375].
Importantly, LC3 recruitment to the phagosomes was not
associated with observable double-membrane structures.
Next to TLR ligand-coated particles, LAP was observed
upon phagocytosis of beads with LPS, killed yeast, or
E. coli bacteria [375]. This indicates that autophagy pro-
teins contribute to the elimination of pathogens not only
through canonical autophagy/xenophagy, but also through
LAP. Finally, a similar decoration of single membrane
structures with LC3 was also described for phagosomes
containing apoptotic cells, macropinosomes, and entotic
vacuoles [376, 377] (reviewed in [378]).
Molecular hierarchy of Atg/ATG proteins
Genetic hierarchy of Atg/ATG proteins
The functional units established by the Atg/ATG proteins
are recruited to the PAS or the phagophore in a defined
order, and historically the analysis of the hierarchical
appearance of Atgs/ATGs has been subject of several
investigations. In 2007, Suzuki et al. reported the hierar-
chy of Atg proteins in PAS organization of yeast [8, 51].
Apparently, Atg17 functions as scaffold for the recruit-
ment of the other Atgs to the PAS. Atg1–Atg13, Atg9 and
the PtdIns3K complex I act in initial stages, whereas
Atg18–Atg2, Atg16–Atg5–Atg12 and Atg8–PE units are
recruited to the PAS subsequently. In 2013, Suzuki et al.
fine-mapped the localization of Atgs during autophago-
some formation in yeast [379]. The authors defined
specific localization sites: (1) the vacuole-isolation
membrane contact site (VICS), (2) the isolation mem-
brane (IM), and (3) the edge of the IM close to the ER
(IM edge). They showed that Atg13, Atg17 and the yeast
PtdIns3K complex I localize to the VICS, whereas Atg1,
Atg8 and the Atg16–Atg5–Atg12 complex label the VICS
and the IM. Finally, Atg2–Atg18 and Atg9 localized at
the IM edge [379].
Itakura et al. performed a hierarchical analysis of
mammalian ATGs [250]. Upon starvation, ULK1, ATG14,
WIPI1, LC3 and ATG16L1 are recruited to the identical
compartment, whereas DFCP1 localizes adjacently to these
ATGs. Apparently, the ULK1 complex is the most
upstream unit, and this unit is required for the recruitment
of the ATG14-containing PtdIns3K class III complex.
Puncta formation of DFCP1 and WIPI1 requires the pres-
ence of FIP200 and ATG14. Finally, LC3 and the
ATG16L1–ATG5–ATG12 complex are the most down-
stream units [250]. Later it could be shown that ATG9A
and FIP200 independently localize to the autophagosome
formation site, but that both are necessary for the recruit-
ment of the downstream factors ATG14 and WIPI1 [265].
Notably, the ATG recruitment hierarchy appears to
depend on the autophagic stimulus. For example, ULK1
and ATG9A localize independently to the autophagosome
formation site during starvation-induced autophagy, mito-
phagy, and Salmonella xenophagy [265, 266]. In contrast,
LC3 recruitment depends on FIP200 and PtdIns3K class III
complex during starvation-induced autophagy, whereas
LC3 recruitment to CCCP-depolarized mitochondria or
Salmonella-containing vacuoles (SCVs) is independent of
FIP200 or ATG9A, respectively [265, 266]. These data
indicate that there exist differences between canonical
autophagy and selective autophagy processes such as
mitophagy or xenophagy. With regard to Salmonella
xenophagy, Noda et al. proposed a ‘‘Three-axis model’’ for
ATG recruitment [380]. In this model, ULK1 and ATG9A
are recruited independently to SCVs. Within the third axis,
LC3 is recruited to SCVs by the ATG16L1 complex, but
this recruitment does not depend on the other factors. The
authors propose that the SCVs might represent an alter-
native membrane target for ATG16L1 recruitment, which
is not present during starvation-induced autophagy [380].
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Temporal hierarchy of Atg/ATG proteins
The above described analyses of the genetic hierarchy of
Atg/ATG proteins revealed the functional interdependence
among the single components. However, this does not
necessarily correspond to the temporal recruitment of Atg/
ATG proteins to the autophagosome formation site. The
temporal aspect of ATG recruitment—i.e., the timing of
accumulation peaks among mammalian ATG proteins—
was addressed by Koyama-Honda et al. [381]. This study
indicates that ULK1 and ATG5 complexes were syn-
chronously recruited, although they are differently
positioned in the genetic hierarchy. This might be
explained by the above-mentioned interaction between
FIP200 and ATG16L1. Furthermore, this observation led
the authors to reassess the dependency of ULK1/ATG5
recruitment on PtdIns3K activity. It appears that both
ULK1 and ATG5 can be stabilized by PtdIns3P at early
stages, and that the ULK1 complex but not the ATG5
complex can become partially PtdIns3P-independent at
later stages of autophagy [381]. Finally, the authors
observe that the different ATGs are recruited to pre-exist-
ing vacuole membrane protein 1 (VMP1)-positive
structures of the ER, although it has previously been sug-
gested that VMP1 functions at a later step of autophagy
[250, 381].
Network of Atg/ATG proteins
In recent years, it became more and more evident that the
genetic interdependence of different ATGs combined with
the differential association and dissociation of ATGs from
the phagophore/autophagosomal membrane allow for the
plasticity of an ATG-dependent autophagic response.
Accordingly, the molecular regulation of autophagy rather
resembles a ‘‘spiderweb-like’’ network than a one-way
signaling cascade (see Fig. 4). Along these lines, different
‘‘signaling and scaffolding platforms’’, which orchestrate
the interplay between Atg/ATGs and non-Atg/ATGs dur-
ing autophagy, have been proposed. For example, the
exocyst complex has been implicated as protein scaffold
for the autophagy machinery. The exocyst is a hetero-oc-
tameric complex involved in post-Golgi trafficking and
vesicle tethering to the plasma membrane [382]. Bodemann
et al. discovered that two exocyst subcomplexes containing
either Sec5 or Exo84 regulate starvation-induced auto-
phagy [383]. In this model, the Sec5 exocyst subcomplex
exhibits a perinuclear localization and harbors the ULK1
kinase and PtdIns3K class III complexes. However, this
subcomplex is autophagy-inactive. Along these lines,
mTORC1 associated with the Sec5-subcomplex. Upon
nutrient-deprivation, the Ras-like small GTPase RalB is
activated, interacts with the exocyst, and promotes the
replacement of Sec5 by Exo84. The Exo84-subcomplex is
autophagy-active, and serves as platform for catalytically
active ULK1 and Beclin 1/VPS34 complexes. Furthermore,
the autophagy-active Exo84-subcomplex is localized to
cytosolic puncta, presumably representing sites of
autophagosome formation [382, 383]. Whereas the exocyst
represents a signaling platform during non-selective star-
vation-induced autophagy, there likely exist corresponding
platforms during selective autophagy processes. Of note,
Deretic and colleagues recently described two alternative
platforms which are connected to xenophagic processes.
They found that tripartite motif protein family (TRIM)
members regulate selective autophagy in multiple ways
[384, 385]. On the one hand, several TRIM family mem-
bers can act as platforms to assemble ULK1- and VPS34/
Beclin 1-complexes (‘‘TRIMosomes’’). On the other hand,
TRIMs can also function as autophagy receptors which
directly bind their cargo, as exemplified by TRIM5 [384,
385]. TRIM5 recognizes and targets HIV-1 for autophagic
destruction by directly binding both the viral capsid and
ATG8 family proteins [384]. By this means, TRIM5
combines scaffolding and receptor properties [384, 385].
Similarly, Deretic and colleagues reported that immunity-
related GTPase family M protein (IRGM)—which is a risk
factor in Crohn’s disease—can assemble the core auto-
phagy machinery and link it to innate immunity receptors,
collectively promoting antimicrobial autophagy [386]. In
the future, additional scaffolding platforms are likely to be
identified.
Conclusion
Over the past 20 years, the signal transduction of auto-
phagy has become a central research field in cell biology.
The molecular understanding of this process has been ini-
tiated by the identification of Atg/ATG proteins, and at
present the network character of this signaling machinery
and the identification of scaffolding/signaling platforms are
shifting into focus. Furthermore, the importance of selec-
tive vs non-selective bulk degradation of cytoplasmic cargo
is more and more appreciated. Generally, autophagic
responses are constituted by two different branches. The
short-term regulation mainly relies on protein–protein
interactions and post-translational modifications such as
phosphorylation, ubiquitination, or acetylation. In contrast,
the long-term regulation of autophagy depends on tran-
scriptional alterations [387], and the crosstalk between
these two regulatory systems represents another important
field of research.
Autophagy and its dysregulation have been implicated
in different human diseases or processes, such as cancer,
neurodegeneration, microbial infections, or aging. It is
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entirely conceivable that the modulation of autophagic
signaling pathways represents a therapeutic target for
several of these (patho-)physiological settings. The detailed
understanding of the autophagy signaling machinery and
its crosstalk is of central importance for the design of tar-
geted therapies. One important example is tumorigenesis.
In recent years, the ambivalent role of autophagy for cancer
development has been characterized. On the one hand, it
was demonstrated that various ATGs suppress tumor
growth and that accordingly different autophagy-compro-
mised mice are tumor-prone, e.g., Becn1?/- mice [388]. In
addition to its tumor suppressing effects, it has been pos-
tulated that autophagy might function as an alternative cell
death mechanism. Collectively, these data form the basis
for various preclinical studies supporting autophagy
induction for cancer treatment [389]. On the other hand,
autophagy functions as a cyto-protective mechanism, and
thus contributes to the survival of cancer cells under
nutrient-deprived conditions frequently found in tumors or
metastasizing cancer cells [390]. Additionally, it could be
shown that these cyto-protective effects support the resis-
tance of cancer cells to metabolic or genotoxic stress
induced by hormonal deprivation, chemotherapy or radia-
tion [6, 389]. Furthermore, some cancer types have been
shown to be ‘‘autophagy addicted’’, and they depend on
autophagy even in the absence of external stresses (e.g.,
RAS-driven cancers) [391]. Accordingly, the disruption of
autophagic signaling pathways has also evolved as a ther-
apeutic strategy and is applied in many preclinical studies
and ongoing clinical trials [389]. In summary, it has been
proposed that the pro- and anti-tumorigenic potential of
autophagy is tumor stage-dependent [392]. Taking this into
consideration, therapies based on autophagy induction
might be beneficial for the prevention of tumorigenesis or
tumor progression, whereas treatments employing the
inhibition of autophagy likely support tumor regression or
enable the overcoming of therapy resistance [6].
So far, the availability of autophagy-inhibiting com-
pounds used in preclinical studies or even clinical trials is
very limited. Currently, all clinical trials pursuing the
inhibition of autophagy make use of the antimalarial
lysosomotropic drugs chloroquine or hydroxychloroquine,
which inhibit the fusion of autophagosomes with lyso-
somes [389]. However, several non-autophagic effects of
these compounds have been reported [389]. With regard to
preclinical studies, additional autophagy-inhibitory regi-
mens have been tested, including bafilomycin A1,
ammonium chloride, 3-methyladenine, or siRNA against
several essential ATGs [389, 391]. However, these com-
pounds are not specific or cannot be employed for clinical
trials. Recently, three different VPS34-selective inhibitors
have been reported, i.e., VPS34-IN1, SAR405, and PIK-III
[255, 393, 394]. For SAR405, the authors reported a
synergistic antiproliferative activity in renal tumor cell
lines in combination with the mTOR inhibitor everolimus
[394]. With regard to the ULK1 complex, the structure of
the ULK1 kinase domain in complex with multiple inhi-
bitors has been reported [118]. Furthermore, recently the
first ULK1/2 inhibitors have been reported and character-
ized, i.e., MRT67307/MRT68921 and SBI-0206965 [124,
395]. Similar to the results obtained with the VPS34-in-
hibitor SAR405, the ULK1-inhibitor SBI-0206965
synergizes with mTOR inhibition to induce cell death in
A549 non-small cell lung cancer cells [124]. Generally, it
has become evident that MTOR inhibitors and other anti-
cancer drugs induce cytoprotective autophagy, ultimately
leading to a compromised efficacy of these compounds.
Therefore, combinatorial therapies employing these agents
and parallel ULK1 and/or VPS34 inhibition represents a
promising anticancer strategy. Collectively, the develop-
ment of targeted therapies—based on the molecular
understanding of the autophagy signaling machinery—will
be a central task for the coming years.
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